Abcès: – palpébral: |
320, 22-23 237, 456-459 |
| Abdomen aigu: |
319, 24-25; 323, 18-19 |
| Ablation par cathéter: |
292, 17 |
| Abstinence alcoolique: |
293, 44-47; 294, 45-46; 305, 40-45; 335, 12-14 |
| Abus sexuel: |
341, 17-18 |
| Accès aux soins: |
297, 48-51; 311, 15-19; 321, 19-20; 334, 13-15 |
Accident: – domestique: – ischémique transitoire: – nucléaire: – vasculaire cérébral: |
210, 60-60 221, 145; 223, 257; 296, 40-44; 313, 19-21; 315, 6-11 205, 332-336 voir AVC |
| Acétazolamide: |
284, 244-253 |
| Acide acétylsalicylique: |
315, 12-13; 321, 11-12 |
| Acide folique: |
236, 384-391; 246, 344-346 |
| Acide gras oméga 3: |
313, 15-16 |
| Acide hyaluronique: |
227, 475-479 |
Acidose: – métabolique: |
292, 28-29 301, 36-44 |
Acné: – rosacée: – vulgaire: |
220, 67; 309, 14-16 299, 34-39 |
| Activité physique: |
291, 16; 323, 20-23; 325, 15-19 |
| Acuité visuelle: |
228, 528-530 |
| Adalimumab: |
341, 13-16 |
| Addiction: |
299, 44-47; 323, 16-17; 340, 6-10; 348, 18-19 |
| Addison (Maladie d’-): |
239, 24-27 |
Adénocarcinome: – œsophagien: |
291, 18 263, 201-205 |
|
Adénopathie:
– médiastinale:
|
211, 145; 215, 357; 236, 418-419; 241, 117; 249, 8-13; 251, 127 327, 26-27 |
| Adjuvant: |
346, 18-21 |
| Adolescence: |
208, 490-495; 221, 124-127; 261, 108-110; 261, 116-121; 263, 211; 271, 112-114; 272, 150-151; 285, 288-289; 302, 24-31; 310, 17-19; 319, 16-17; 334, 21-22; 340, 6-10; 344, 22-23 |
| Adrénaline: |
250, 70-74 |
| Aérateur transtympanique: |
331, 11-13 |
| Aérosol: |
199, 8-12; 335, 12-14 |
| Agents biologiques: |
337, 19-20 |
| Agglutinines irrégulières: |
204, 276-277 |
| Agitation: |
220, 91; 229, 8-15; 294, 26; 318, 20-22; 343, 16-17 |
| Agressivité: |
222, 196-198; 309, 25-26 |
| Akinésie: |
217, 448-453 |
| Albuminurie: |
301, 36-44 |
| Alcool: |
209, 37-39; 231, 145; 246, 344-346; 280, 66-67; 282, 160-161; 282, 167; 291, 46-49; 293, 24; 293, 44-50; 295, 8-15; 302, 16-18; 302, 24-31; 303, 18-20; 304, 34-41; 304, 56-59; 305, 40-45; 312, 27-28; 313, 24-25; 314, 6-14; 314, 23-24; 317, 19-20; 320, 22-23; 323, 12-13; 323, 16-17; 324, 10-12; 334, 21-22; 335, 12-14; 347, 18-19; 348, 18-19 |
| Algie vasculaire de la face: |
228, 535 |
| Algodystrophie: |
208, 486-489, 262, 149 |
| Algologie: |
341, 13-16 |
| Alimentation: |
303, 44-49; 308, 30-33; 310, 20-22; 317, 15-16; 322, 16-18; 329, 12-14 |
| Allaitement maternel: |
228, 522-526; 234, 276-284; 302, 24-31; 308, 30-33 320, 17; 334, 21-22; 337, 11 |
|
Allergie:
– alimentaire: – de contact: – médicamenteuse: – respiratoire:
|
213, 253; 232, 168-174; 232, 192-197; 242, 152-156; 250, 70-74; 261, 123; 274, 244-251; 333, 21-22 308, 30-33; 330, 16-17 280, 61 234, 302-309; 331, 6-10 338, 14-16 |
| Allopuriol: |
291, 18 |
| Alopécie: |
219, 35-38; 239, 24-27; 347, 14-15 |
| Altitude: |
284, 244-253 |
| Alzheimer: |
201, 112-116; 258, 424-431; 291, 46-49; 296, 8-18; 300, 22-24; 304, 42-47; 306, 44-48; 317, 6-14; 317, 15-16; 343, 16-17 |
| Amaigrissement: |
343, 23-24 |
| Amaurose: |
226, 410-414; 311, 23-25 |
| Aménorrhée: |
219, 41; 300, 26-34; 316, 23-25 |
| Amiodarone: |
282, 169; 332, 17-21 |
| Ampullome: |
286, 338-339 |
| Analgésie: |
210, 66-67; 228, 510-512; 295, 54-60 |
| Analgésiques morphiniques: |
290, 32-41; 294, 18 |
| Analogues GLP-1 |
312, 6-12 |
| Anaphylaxie: |
307, 8-10; 316, 18-19; 338, 14-16 |
| Anatomopathologie: |
227, 444-451; 227, 464-468 |
| Anémie: |
199, 41; 236, 384-391; 292, 24-25; 292, 28-29; 294, 25-26; 294, 45-46; 294, 48-51; 324, 19-20 |
Anesthésie: – locale: |
203, 208-212; 231, 120-123; 307, 8-10 210, 66-67 |
Anévrysme: – de l’aorte abdominale: – intracrânien: |
297, 24-32 293, 33; 301, 16-18 |
| Angine: |
252, 144-149; 303, 22-23 |
| Angiofibrome: |
329, 15-16 |
| Angio-œdème: |
331, 6-10; 338, 20-24 |
| Angor: |
285, 300-301; 309, 14-16 |
Angiome: – veineux: |
263, 197 300, 20-21 |
| Anite: |
341, 17-18 |
| Anneau vaginal: |
299, 34-39 |
| Anorexie: |
310, 20-22 |
| Anormalité oculaire: |
305, 18-19 |
| Anosmie: |
332, 24-25 |
| Antalgiques: |
223, 242-250; 228, 510-512; 305, 8-12; 332, 6-11 |
| Antagonistes adrénergiques: |
300, 22-24 |
| Anti-acides: |
332, 12-14 |
| Anti-agrégant plaquettaire: |
262, 156-159; 296, 8-18; 348, 15 |
| Antibioprophylaxie: |
311, 6-10 |
| Antibiotiques: |
202, 178-180; 257, 386-389; 291, 17; 302, 16-18; 305, 8-12; 307, 8-10; 318, 16-17; 319, 16-17; 328, 13-14; 340, 11-13; 340, 23-24 |
| Anticholinestérasiques: |
313, 19-21; 343, 16-17 |
| Anticoagulants: |
209, 28-33; 291, 28-29; 293, 8-20; 296, 8-18; 306, 8-10; 307, 50-52; 319, 20-21; 333, 11-13 |
Anticorps: – antinucléaires: – monoclonaux: |
295, 34-43 247, 407; 333, 17-18 |
| Antidépresseurs: |
311, 11-12; 312, 13-14; 316, 20-22; 317, 19-20; 317, 23-24; 326, 11-12; 327, 16-17; 328, 10-12; 330, 16-17; 344, 16-18 |
| Antidiabétiques oraux: |
244, 258-263; 270, 67-69 |
| Anti-épileptiques: |
313, 19-21 |
| Antigènes urinaires: |
281, 122-123 |
| Anti-histaminique: |
223, 233-235 |
| Anti-inflammatoires: |
302, 16-18; 340, 11-13 |
| Antiplaquettaires: |
315, 12-13 |
| Antipsychotiques: |
242, 168-174 |
| Antithyroïdiens: |
341, 13-16 |
| Anti-TNF: |
271, 96-105; 332, 22-23 |
| Antitussif: |
208, 484-485 |
| Antiviraux: |
292, 16; 345, 6-11 |
| Anti-vitamine K: |
293, 8-20 |
| Anus: |
264, 239 |
| Anxiété: |
331, 16-18 |
| Aphtose buccale: |
342, 13 |
| Apnée: |
257, 376-383; 326, 6-10; 338, 11-13 |
| Aponévrose plantaire: |
247, 395 |
| Aponévrosite: |
301, 16-18 |
| Apophysose: |
210, 80-85 |
| Appendalgie: |
262, 165 |
| Appendicite: |
289, 20-23; 301, 46-49; 305, 22-28 |
Aptitude – à la conduite automobile: – professionnelle: – sportive: |
344, 16-18 290, 14-16 271, 112-114 |
| Arrachement apophysaire: |
283, 195 |
| Arrêt cardio-respiratoire: |
221, 132-139; 292, 19 |
Artériopathie: – des membres inférieurs: |
213, 216-222 286, 347 |
| Artérite: |
208, 501; 305, 52-54 |
| Arthralgie: |
292, 32-34; 336, 19-21 |
Arthrite: – juvénile: – microcristalline: – réactionnelle: – septique: |
298, 44-50; 306, 24-32; 326, 13-14; 327, 26-27 239, 8-15 333, 17-18 258, 435 246, 353-357; 295, 64-66; 298, 44-50 |
| Arthroplastie de hanche: |
303, 26-31 |
| Arthroscopie: |
309, 11-12 |
Arthrose: – de hanche: |
227, 475-479; 291, 19; 326, 11-12 330, 16-17 |
| Articulation coxo-fémorale: |
239, 8-15 |
| Arythmie: |
209, 28-33; 248, 435 |
| Aspergillus: |
227, 481; 261, 123 |
| Aspirine: |
275, 288-295; 279, 25-30; 281, 96-103; 299, 18-20; 301, 8-15 |
| Assistance par téléphone: |
297, 18-20 |
| Assurance: |
306, 44-48; 338, 19-22 |
| Asthme: |
216, 390-393; 250, 70-74; 261, 123; 268, 413; 274, 244-251; 299, 26-32; 300, 40-46; 316, 18-19; 324, 13-14; 333, 21-22; 337, 21-23; 338, 14-16 |
| Ataxie: |
254, 248-255; 324, 10-12 |
| Athérogenèse: |
237, 469-472 |
| Atopie: |
232, 168-174; 232, 192-197; 318, 16-17; 333, 21-22 |
| Attachement (Troubles de l’-): |
206, 364-368 |
| Attitude: |
199, 38-39 |
| Audition: |
231, 112-117; 231, 128-131 |
| Aura migraineuse: |
313, 19-21 |
| Auto-évaluation: |
204, 282-287 |
| Automutilation: |
319, 16-17 |
| Autonomie: |
242, 179; 309, 17-22; 319, 20-21 |
| AVC: |
212, 184-186; 219, 17-18; 241, 118-120; 293, 23; 296, 40-44; 299, 34-39; 306, 8-10; 315, 6-11; 315, 12-13; 316, 18-19; 321, 11-12 |
| |
(haut de la page)
|
| Baclofène: |
293, 47-50; 302, 24-31; 314, 6-14; 347, 18-19; 348, 18-19 |
| Bactérie multi-résistante: |
322, 6-11 |
| Bactériurie: |
292, 23-24 |
| Balanite: |
269, 35; 292, 23-24; 347, 16-17 |
| Balanoposthite: |
347, 16-17 |
| Balint: |
307, 46-48 |
| Banc solaire: |
300, 16-18 |
| Bandelette ilio-tibiale: |
243, 196-199 |
| Bandelette urinaire: |
292, 27-28 |
| Bartonella: |
251, 127 |
| Benzodiazépines: |
299, 44-47; 300, 22-24; 304, 34-41; 313, 24-25; 317, 15-16; 317, 19-20 |
| Bêta-bloquant: |
310, 13-14; 311, 11-12; 312, 13-14; 325, 20-21 |
| Bêta-lactamase à spectre étendu (BLSE): |
322, 6-11 |
| Bethesda 2001: |
227, 444-451; 227, 464-468 |
| Bigéminisme ventriculaire: |
260, 79 |
Bilan: – hydrique – préopératoire: – santé: |
257, 364-369 231, 120-123 202, 164-166; 301, 16-18 |
| Binge drinking: |
323, 12-13; 323, 16-17; 324, 10-12; 334, 21-22 |
| Biologie clinique: |
256, 320-325; 290, 21-25; 294, 44-45 |
| Biothérapie: |
271, 96-105; 298, 44-50; 333, 17-18 |
| Biphosphonates: |
214, 292-294; 300, 26-34; 324, 19-20 |
| Bisphénol A: |
348, 20-21 |
| Blastocystis hominis: |
297, 54-56 |
| Blépharite: |
311, 23-25 |
| Blépharospasme: |
282, 152-157 |
Bloc: – A-V: – de branche droit – de branche gauche complet: |
221, 128-131 248, 435 199, 26-29 |
| BNP: |
224, 282-285; 306, 24-32 |
| Boiterie: |
229, 22-25; 239, 8-15; 305, 22-28; 308, 30-33 |
| Borréliose: |
274, 255; 284, 228-233; 308, 34-38; 325, 10; 330, 20-22; 337, 14-15 |
| Boulimie: |
310, 20-22 |
| Bowen (maladie de -): |
236, 406-412 |
| BPCO: |
216, 376-382; 216, 390-393; 249, 21; 272, 160-161; 298, 8-18; 298, 20-23; 307, 22-28; 311, 11-12; 312, 13-14; 315, 12-13; 320, 17; 321, 15-16; 324, 13-14; 337, 11 |
| Bronchiectasies: |
218, 498-505 |
| Bronchiolite: |
241, 118-120; 299, 26-32; 335, 12-14; 337, 6-10 |
Bronchite: – aiguë: |
301, 24-28 310, 13-14 |
| Bronchodilatateur: |
321, 15-16; 337, 6-10 |
| Brugada: |
248, 435 |
Brûlure: – oculaire: |
203, 229-235; 204, 278-281 226, 410-414 |
| Bulle hémorragique: |
303, 22-23 |
| Buprénorphine: |
216, 396-403; 267, 358-362 |
| Burnout: |
303, 18-20; 305, 14-16; 305, 22-28; 306, 24-32; 315, 21-24; 331, 16-18; 341, 6-12; 348, 20-21 |
| Bursite: |
243, 196-199; 259, 26-29; 290, 18-19 |
| Bypass gastrique: |
307, 30-45 |
| |
(haut de la page)
|
| Café: |
296, 40-44 |
| Calcanéum: |
221, 112-120 |
| Calcémie: |
341, 19-22 |
| Calcitonine: |
208, 486-489 |
| Calcium: |
300, 26-34; 332, 12-14 |
| Calprotectine: |
294, 45 |
Canal: – carpien: – lombaire étroit: |
199, 23 264, 228-232; 305, 22-28; 333, 11-13 |
|
Cancer:
– cervico-facial: – colique: – colorectal:
– cutané: – de la prostate:
– de l’endomètre: – du col:
– du foie: – du poumon:
– du rein: – du sein:
– gastrique: – métastasé: – oropharyngé: – thyroïdien:
|
270, 52-59; 298, 20-23; 311, 11-12; 312, 13-14; 319, 22-23; 321, 6-10; 321, 17-18; 329, 12-14; 332, 22-23 210, 72-73 256, 347 224, 304-307; 259, 8-15; 260, 52-59; 299, 18-20; 313, 22-23 300, 16-18 225, 344-345; 289, 20-23; 292, 29-30; 293, 22; 296, 40-44; 315, 12-13; 315, 16-20 289, 20-23 222, 176-179; 250, 64-65; 300, 26-34; 315, 21-24; 345, 20-21 200, 88-89 275, 317; 290, 14-16; 300, 40-46; 314, 15-16; 315, 12-13; 321, 22-23; 333, 11-13; 335, 20-21 291, 46-49 218, 509; 221, 121; 222, 195; 224, 291; 225, 344-345; 226, 421-423; 240, 64-69; 254, 244-245; 269, 28-30; 301, 16-18; 306, 12-19; 308, 8-10; 312, 17-22; 314, 15-16; 319, 16-17 332, 22-23 315, 12-13 319, 26-27; 324, 13-14 205, 332-336; 270, 70-73 |
| Candida albicans: |
202, 174-177; 269, 35 |
| Candidose: |
336, 13-14 |
| Cannabis: |
208, 490-495; 317, 19-20 |
| Capsulite rétractile: |
225, 350-353 |
Carcinome: – basocellulaire: – cuniculatum: – cutané: – épidermoïde: – spinocellulaire: |
206, 397 236, 406-412; 270, 63; 289, 8-19; 289, 24-25 319, 18-19 285, 281 291, 20-21; 319, 18-19 289, 8-19; 291, 20-21 |
| Cardiomyopathie: |
319, 26-27; 331, 23-24 |
| Cardioversion: |
209, 28-33 |
| Carie: |
324, 10-12 |
Carence: – martiale: – nutritionnelle: |
199, 41 307, 12-19; 310, 20-22 |
| Carotide: |
306, 8-10 |
| Carré de Whitel |
330, 20-22 |
| Catalepsie: |
292, 54-55 |
| Cataracte: |
226, 388-392; 311, 23-25 |
| CDT: |
282, 160-161 |
| Cécité: |
234, 297-298 |
| Cellulite (péri)orbitaire: |
227, 460-463; 294, 40-43 |
| Céphalée: |
228, 535; 236, 421; 276, 361; 293, 30-31; 294, 54-56; 298, 52-54; 299, 22-24; 308, 52-53; 313, 19-21; 322, 12-13; 326, 23-24; 332, 6-11; 341, 23-24 |
Certificat: – d’aptitude au sport: – de décès: |
336, 17-18; 347, 21-23 225, 332-341 + addenda |
| Chagrin: |
290, 14-16 |
| Chalazion: |
237, 456-459 |
| Champ visuel: |
228, 528-530 |
| Chancre: |
286, 343-345 |
| Chaussures: |
313, 15-16 |
| Cheveux: |
219, 35-38 |
| Cheville: |
214, 272-277; 296, 48-55 |
| Chicha: |
263, 184-188 |
| Chikungunya: |
335, 12-14 |
| Chimiothérapie: |
253, 202-209; 315, 12-13; 340, 11-13 |
Chirurgie: – bariatrique:- esthétique: – orthopédique: – thoracique: |
307, 22-28; 338, 11-13 296, 40-44; 303, 44-49; 307, 12-19; 307, 30-45; 309, 23-24; 326, 15-17 220, 85-89 280, 63-65 297, 8-16 |
| Chlamydia trachomatis: |
290, 48-51; 298, 26-29 |
| Chlore: |
274, 244-251 |
| Choc anaphylactique: |
250, 70-74 |
| Choix du patient: |
285, 282-285 |
| Choléra: |
298, 26-29 |
| Cholestase: |
273, 216-221; 286, 338-339 |
| Cholestéatome: |
209, 8-12 |
| Chômage: |
302, 42-44 |
| Chondrocalcinose: |
246, 353-357 |
| Chutes: |
204, 260-264; 275, 317; 286, 326-329; 311, 26-27 |
| Cicatrisation: |
303, 18-20 |
| Cils: |
222, 180-183 |
| Cinquième maladie: |
348, 16-17 |
Cirrhose: – alcoolique: – hépatique: |
318, 23-25 200, 88-89; 225, 356-360; 291, 46-49; 291, 52-54; 294, 46; 302, 24-31 |
| Claquage: |
213, 244-246 |
| Clarithromycine: |
311, 11-12; 312, 13-14 |
Claudication: – intermittente: |
264, 228-232; 286, 347; 305, 22-28 208, 501 |
| Clearance de la créatinine: |
222, 189-191; 283, 200-203 |
| Cloison nasale: |
240, 73 |
| Clopidrogel: |
258, 435 |
| Clostridium difficile: |
298, 26-29 |
| Cluster headache: |
228, 535; 313, 19-21 |
| CMV: |
231, 145; 246, 344-346 |
| Codéine: |
320, 17 |
| Coenzyme Q10: |
322, 12-13 |
| Coiffe des rotateurs: |
228, 500-507; 251, 101-107 |
| Colchicine: |
344, 12-13 |
| Coliques du nourrisson: |
337, 11 |
| Colique néphrétique: |
331, 11-13 |
| Colite spasmodique: |
300, 16-18 |
| Colobome: |
305, 18-19 |
| Côlon irritable: |
300, 16-18; 328, 10-12; 332, 22-23 |
| Colonoscopie: |
224, 304-307; 259, 8-15; 260, 52-59 |
| Colopathie fonctionnelle: |
326, 11-12; 327, 16-17; 328, 10-12 |
| Coma: |
303, 44-49 |
| Communication: |
199, 38-39; 203, 220-221; 212, 173-175; 238, 526-527; 297, 24-32; 312, 17-22; 315, 21-24; 321, 19-20; 336, 22-24 |
| Comorbidité: |
306, 8-10; 306, 24-32; 321, 19-20 |
| Compétence: |
306, 24-32; 314, 21-22 |
| Compliance: |
213, 226-227; 315, 21-24; 315, 21-24 |
| Comportement alimentaire: |
322, 16-18 |
| Compréhension: |
199, 38-39 |
| Compression médullaire: |
289, 48-49 |
| Concertation multidisciplinaire: |
329, 12-14 |
| Conduite addictive: |
305, 40-45 |
| Conduite automobile: |
227, 454-456 |
| Condylome: |
329, 15-16; 345, 20-21 |
| Confiance: |
199, 38-39 |
Conflit: – radiculaire: – antérieur de hanche: |
222, 196-198 229, 30-37 232, 198-199 |
| Confusion: |
201, 112-116; 239, 43; 296, 58-61; 344, 16-18 |
Conjonctivite: – allergique: |
325, 11-12 311, 23-25; 338, 14-16 |
| Conjonctivochalasis: |
340, 19-20 |
Conseil: – hygiéno-diététique: – minimal |
311, 6-10 252, 157-158; 272, 147-148; 272, 183 |
| Consommation d’alcool: |
293, 44-49; 305, 40-45; 313, 24-25 |
| Constipation: |
200, 91; 301, 16-18; 329, 12-14; 330, 16-17 |
Consultation: – complexe: |
214, 280-281; 297, 24-32 309, 11-12 |
Contention: – physique: |
303, 26-31 294, 26 |
| Continuité des soins: |
346, 15 |
| Contraception: |
213, 226-227; 221, 124-127; 293, 24; 296, 8-18; 298, 20-23; 299, 34-39; 316, 23-25; 325, 13-14 |
| Contusion: |
203, 229-235 |
| Convulsions: |
329, 12-14 |
| Coqueluche: |
220, 70-73; 266, 321-323; 333, 23-24 |
| Cordon fibreux: |
327, 18-19 |
| Cornée: |
204, 278-281; 259, 19 |
| Corps étranger: |
203, 229-235; 259, 19 |
Corticoïdes: – inhalés: |
331, 14-15 301, 16-18 |
| Corticothérapie: |
275, 304-306; 300, 22-24; 320, 17 |
| Cosmétique: |
259, 22-23 |
| Cotinine: |
251, 112-115; 272, 162-165 |
| Coude: |
296, 48-55 |
| Couple: |
215, 346-352 |
| Coups et blessures (constat de -): |
237, 440-447 |
| Coxa plana: |
229, 22-25 |
| Coxsackie: |
205, 328-331 |
| Craving: |
305, 40-45 |
| Créatinine sérique: |
292, 28-29 |
| Critères d’Ottawa: |
312, 23-24 |
Croissance: – staturale: |
220, 60-66 301, 16-18 |
| Cruralgie: |
305, 52-54 |
| Cryothérapie: |
329, 12-14 |
| Cryptorchidie: |
247, 380-385 |
| Curetage: |
329, 12-14 |
| Cycle menstruel: |
326, 18-22 |
| Cystite: |
292, 23-24; 311, 6-10 |
| Cytolyse: |
273, 216-221; 277, 405; 325, 22-23 |
| |
(haut de la page)
|
| Datura: |
273, 211 |
| D-dimères: |
246, 363 |
| Décision médicale: |
315, 21-24; 334, 17-18 |
| Décision partagée: |
347, 18-19 |
| Déchirure musculaire: |
213, 244-246 |
| Déclaration obligatoire: |
274, 266-267; 274, 270; 277, 401; 278, 447; 298, 32-38 |
Décollement: – apophysaire: – de la rétine: – postérieur du vitré |
222, 164-173; 223, 220-228 311, 23-25 311, 23-25 |
| Décompensation cardiaque: |
199, 26-29; 295, 54-60; 314, 15-16 |
| Décontamination: |
218, 480-485 |
| Déclin fonctionnel: |
299, 26-32 |
| Défibrillateur: |
325, 20-21 |
| Défibrillation précoce: |
221, 132-139 |
Déficit cognitif: – modéré: |
296, 8-18; 309, 17-22 310, 13-14 |
| Déficit d’extension d’une main: |
338, 17-18 |
| Dégénérescence maculaire liée à l’âge (DMLA): |
328, 17-21 |
| Délire: |
264, 241; 299, 26-32 |
| Delirium: |
320, 22-23 |
|
Démence:
– sénile:
|
201, 112-116; 294, 17; 297, 18-20; 304, 42-47; 307, 8-10; 309, 17-22; 310, 13-14; 311, 11-12; 312, 13-14; 313, 19-21; 317, 6-14; 317, 15-16; 318, 20-22; 319, 20-21; 323, 20-23; 340, 18; 344, 16-18 311, 26-27 |
| Dénervation sympathique: |
301, 30-35 |
| Dengue: |
298, 26-29; 315, 25-26 |
| Déni: |
202, 156-160 |
| Densitométrie osseuse: |
213, 236-238; 293, 24; 300, 26-34; 303, 8-17; 304, 8-24 |
| Dents: |
324, 10-12 |
| Dénutrition: |
289, 34-41; 295, 54-60; 307, 22-28 |
| Déontologie: |
204, 268-272 |
|
Dépendance:
– au jeu:
|
232, 178-180; 299, 44-47; 304, 56-59; 306, 44-48; 317, 19-20 325, 13-14 |
|
Dépistage:
– cardiovasculaire: – du cancer: – neurosensoriel: – prénatal non invasif:
|
202, 170-172; 218, 509; 222, 195; 224, 291; 224, 304-307; 225, 344-345; 226, 421-423; 243, 202-203; 254, 244-245; 260, 52-59; 266, 338-340; 270, 70-73; 297, 24-32; 298, 20-23; 308, 40-51; 312, 17-22; 313, 15-16; 315, 16-20; 315, 21-24; 322, 12-13; 323, 20-23; 336, 13-14 236, 395-396; 309, 14-16 290, 14-16; 309, 11-12; 319, 16-17; 321, 17-18 323, 20-23 323, 20-23 |
|
Dépression:
– bipolaire: – de la personne âgée:
|
200, 60-64; 209, 41; 232, 201; 233, 259-261; 241, 126-130; 242, 179; 270, 79; 279, 37; 294, 17; 294, 26-27; 297, 18-20; 302, 16-18; 306, 24-32; 309, 11-12; 311, 11-12; 312, 13-14; 317, 23-24; 331, 16-18; 336, 13-14; 348, 20-21 282, 140-145; 344, 12-13 344, 16-18 |
Dermatite: – atopique: – périorale: – séborrhéique: – atopique: |
322, 19-21 331, 14-15 319, 16-17 217, 438-440; 232, 168-174 |
| Dermatologie: |
297, 24-32; 307, 22-28; 338, 20-24 |
| Dermatophytose: |
282, 149; 311, 13-14; 344, 14-15 |
Dermatose: – cendrée: – héréditaire: – transitoire: |
332, 12-14 230, 78-81 336, 15-16 337, 12-13 |
| Dermite des chaufferettes: |
226, 404-407 |
| Dermocorticoïdes: |
323, 12-13 |
| Désensibilisation: |
242, 152-156; 338, 14-16 |
| Déshydratation: |
239, 43; 301, 24-28; 338, 19-22 |
| Désinsertion tendineuse: |
200, 69 |
| Détresse respiratoire: |
304, 42-47 |
| Deuil: |
211, 112-119; 317, 23-24 |
| Développememnt durable: |
209, 16-17 |
| Développement ectopique mélanocytaire: |
340, 14-15 |
|
Diabète:
– gestationnel:
|
205, 322-325; 213, 216-222; 235, 350-355; 244, 258-263; 266, 328-333; 268, 410-411; 269, 35; 270, 67-69; 271, 123; 279, 8-15; 279, 25-30; 284, 240-241; 285, 304-306; 296, 40-44; 301, 8-15; 305, 14-16; 306, 8-10; 309, 14-16; 310, 13-14; 312, 6-12; 319, 20-21; 321, 15-16; 323, 20-23; 324, 13-14; 329, 12-14; 334, 10; 335, 12-14; 335, 20-21; 336, 13-14; 338, 19-22; 340, 18; 348, 15 319, 16-17 |
| Diagnostic: |
336, 22-24 |
| Diapneusie: |
338, 12-13 |
|
Diarrhée:
– chronique: – médicamenteuse:
|
209, 41; 235, 361-363; 237, 460-463; 297, 54-56; 298, 26-29 247, 407; 268, 429; 309, 14-16 341, 13-16 |
| Diphtérie: |
206, 372-374; 220, 70-73 |
| Diplopie: |
228, 528-530; 291, 38-44; 303, 52-55; 341, 23-24 |
| Disponibilité: |
214, 280-281 |
Dispositif: – intra-utérin: – transdermique hormonal: |
299, 34-39; 345, 22-24 299, 34-39 |
| Dissection aortique: |
201, 139 |
| Disulfirame: |
293, 47 |
| Diurétiques: |
211, 124-126; 301, 36-44; 310, 13-14; 332, 12-14 |
| Diversification alimentaire: |
333, 21-22 |
| Diverticulite: |
257, 391; 338, 11-13 |
| DMLA: |
311, 23-25 |
| Doigt en maillet: |
200, 69 |
| Dopage: |
216, 386-387 |
| Dopamine: |
329, 12-14 |
| Dorsalgies: |
204, 293; 205, 347; 307, 20-21 |
| Dosage urinaire: |
279, 20-21 |
Dossier médical: – global: – G+: – informatisé: |
206, 390-393; 210, 89-91; 307, 22-28 281, 108-109 281, 112-113; 308, 40-51 235, 343-344; 240, 84-89; 249, 16-17 |
|
Douleur:
– abdominale:
– anale: – articulaire: – chronique: – du pied: – inguinale: – musculaire: – musculosquelettique: – neuropathique: – oculaire: – pelvienne: – post-zostérienne: – scapulaire: – thoracique:
|
210, 66-67; 228, 510-512; 290, 32-41; 290, 44-45; 340, 11-13; 345, 18-19 214, 311; 216, 411; 238, 528-529; 257, 391; 262, 165; 284, 255; 289, 20-23; 297, 54-56; 301, 46-49; 305, 22-28; 309, 27-28; 326, 11-12; 327, 16-17; 328, 22-23; 336, 19-21 343, 16-17 270, 79; 308, 30-33 223, 242-250 328, 13-14 305, 52-54 293, 26-27 274, 271 223, 242-250; 247, 400-405 325, 11-12 261, 96-103 341, 13-16 305, 22-28 218, 488-491; 249, 35; 297, 24-32; 302, 46-49 |
| Drogues: |
279, 20-21 |
| Droits du patient: |
203, 220-221; 304, 42-47 |
| DSM IV: |
241, 126-130 |
| Dysautonomie: |
252, 169 |
| Dysfonction érectile: |
293, 23; 303, 32-41 |
| Dyshidrose: |
320, 18-19 |
| Dyslipidémie: |
225, 344-345 |
| Dysménorrhée: |
326, 18-22 |
| Dyspareunie: |
245, 315 |
| Dysphagie: |
294, 54-56 |
| Dysphonie: |
321, 22-23 |
Dysplasie: – cervicale: – coxo-fémorale: |
300, 26-34 232, 198-199 |
| Dyspnée: |
199, 41; 203, 229-235; 221, 128-131; 259, 35; 261, 107; 268, 413; 295, 54-60; 301, 24-28; 306, 24-32; 307, 22-28; 322, 12-13 |
Dystonie: – de fonction: |
282, 152-157 238, 512-521 |
| Dystrophie unguéale: |
308, 26-27 |
| |
(haut de la page)
|
| EBM: |
202, 178-180; 211, 124-126; 225, 344-345; 231, 138-140; 245, 307-309; 262, 140-145; 297, 34-46; 300, 26-34; 301, 8-15; 306, 34-41; 314, 21-22; 321, 19-20 |
| E-cigarette: |
278, 436-439; 325, 13-14; 333, 6-10 |
| Ecchymose: |
218, 511 |
| Echauffement musculaire: |
298, 20-23 |
| Echec thérapeutique: |
291, 17 |
| Echelonnement: |
321, 19-20 |
| Echocardiographie: |
306, 24-32 |
| Echographie: |
305, 22-28; 347, 6-13 |
| Eclampsie: |
305, 22-28 |
| Economie de la santé: |
334, 17-18 |
| Ecoute: |
199, 38-39; 200, 82-84; 212, 173-175; 214, 280-281 |
| Ecthyma: |
312, 15-16 |
|
Eczéma:
– atopique: – de contact: – séborrhéique:
|
232, 168-174; 232, 192-197; 246, 349; 250, 67; 253, 199; 274, 244-251; 320, 18-19; 333, 21-22 304, 34-41; 323, 12-13 276, 345; 280, 61 319, 16-17 |
| Education à la santé: |
200, 82-84; 298, 8-18; 323, 20-23 |
| Effet atopinique: |
273, 211 |
| Effet iatrogène: |
302, 16-18; 304, 26-28; 304, 30-31; 308, 52-53; 326, 11-12; 328, 10-12 |
| Effets indésirables: |
255, 276-281; 259, 22-23; 302, 32-40; 308, 52-53 |
| Effets secondaires: |
199, 30-34; 200, 82-84; 318, 16-17 |
| Ejaculation prématurée: |
290, 8-13; 291, 8-15 |
| Electrocardiogramme (ECG): |
221, 128-131; 232, 186-189; 248, 435; 316, 6-13; 336, 17-18; 341, 19-22; 347, 21-23 |
| Electrolytes: |
341, 19-22 |
| Elongation: |
213, 244-246 |
Embolie: – pulmonaire: |
345, 12 201, 122-124; 246, 363; 293, 24 |
Embolisation: – thérapeutique: |
230, 86-91 293, 33 |
| Emotions: |
237, 475-476; 309, 25-26 |
| Empathie: |
219, 8-13; 237, 475-476; 238, 526-527; 290, 14-16; 302, 16-18; 315, 21-24 |
Encéphalite: – à tiques: – japonaise: |
298, 26-29; 308, 34-38 298, 26-29 |
| Encéphalopathie: |
312, 27-28 |
| Encodage: |
210, 89-91; 240, 84-89 |
| Endobrachyœsophage: |
263, 201-205 |
| Endocardite: |
256, 347 |
| Endomètre: |
289, 20-23 |
| Endométriose: |
261, 96-103 |
| Endoscopie: |
335, 20-21 |
| Enfant: |
332, 6-11 |
| Engelure: |
207, 432-435 |
| Enseignement: |
335, 17-19 |
| Entérite: |
294, 45 |
Entorse: – de cheville: – de poignet: – du genou: |
214, 272-277; 241, 118-120; 312, 23-24 219, 24-27 222, 164-173; 223, 220-228 |
| Entretien motivationnel: |
295, 8-15 |
| Enurésie nocturne: |
206, 382-388; 292, 19 |
| Environnement: |
211, 122-123; 332, 22-23 |
| Epanchement articulaire: |
202, 188-189; 259, 26-29; 323, 14-15 |
| Epaule: |
228, 500-507; 251, 101-107; 266, 325; 305, 22-28 |
| Epicondylalgie: |
240, 74-80 |
| Epidémie de grippe: |
243, 223 |
| Epidémiologie: |
219, 17-18 |
| Epigastralgies: |
232, 186-189; 323, 18-19; 326, 23-24 |
| Epiglottite: |
316, 18-19 |
| Epilepsie: |
231, 145; 316, 18-19 |
| Epithelioma spinocellulaire: |
285, 281 |
| Epistaxis: |
240, 73 |
| Epuisement professionnel: |
329, 6-11; 348, 20-21 |
| Erection: |
315, 12-13 |
| Ergonomie: |
283, 186-191 |
Erosion: – articulaire |
204, 278-281; 259, 19 271, 96-105 |
Erreur: – médicale: |
297, 24-32 338, 19-22; 342, 23-24 |
|
Eruption:
– bulleuse: – cutanée: – érythémateuse: – pédiatrique: – vésiculeuse:
|
200, 78-81; 211, 128-131; 218, 494-497; 220, 74-77; 226, 404-407; 227, 460-463; 230, 78-81; 231, 124-127; 233, 240-243; 235, 347-348; 239, 24-27; 241, 117; 243, 209; 287, 371; 311, 13-14; 316, 16-17; 331, 6-10; 332, 15-16; 346, 23-24 238, 506-509; 322, 14-15 315, 25-26; 338, 14-15 213, 230-233 348, 16-17 205, 328-331 |
| Erysipèle: |
245, 299; 335, 12-14 |
Erythème: – infectieux: – migrant: – noueux: – polymorphe majeur: |
202, 174-177 233, 240-243 325, 10 280, 81; 346, 23-24 251, 111 |
| Erythropoïétine: |
292, 24-25 |
| Escarres: |
342, 6-12 |
| Etat de choc: |
305, 22-28 |
| Ethinylestradiol: |
299, 34-39 |
| Ethique: |
230, 64-67; 266, 336-337; 266, 338-340; 323, 20-23; 329, 12-14; 333, 11-13; 336, 6-12; 340, 11-13 |
| Euthanasie: |
230, 60-63; 230, 64-67; 230, 82-84; 304, 42-47; 340, 18 |
Evaluation: – des risques: – gériatrique: |
199, 16-20; 209, 22-23; 230, 70-72; 279, 33-35 302, 32-40 309, 6-10 |
Examen: – clinique: – complémentaire: |
329, 17-19 329, 17-19 |
| Exanthème: |
332, 15-16 |
| Excrétion rénale: |
321, 15-16 |
| Exenatide: |
266, 328-333 |
| Exercice physique: |
310, 13-14; 325, 15-19 |
| Exophtalmie: |
226, 388-392; 294, 20-22 |
| Expectoration: |
218, 498-505; 294, 44-45 |
| Extenseur du doigt: |
200, 69 |
Extrasystole: – ventriculaire: |
265, 281 325, 20-21 |
| |
(haut de la page)
|
Facteur de risque: – cardiovasculaire: – des chutes: – génétique: |
204, 293; 333, 11-13 204, 260-264 336, 13-14 |
| Facteur rhumatoïde: |
333, 17-18 |
| Facteurs socio-économiques: |
296, 8-18 |
| Faiblesse musculaire: |
291, 38-44 |
| Famille: |
215, 346-352 |
| FAN: |
333, 17-18 |
Fasciite: – nécrosante: – plantaire: |
301, 16-18 335, 12-14 328, 13-14 |
| Fatigue: |
200, 60-64; 231, 138-140; 261, 107; 325, 22-23 |
| Fécondation: |
248, 438-445 |
| Feed-back: |
199, 38-39 |
| Fer: |
294, 48-51; 310, 20-22 |
| Ferritine: |
294, 49-50; 310, 20-22 |
| Fertilité: |
248, 438-445 |
| Fibrates: |
301, 36-44 |
| Fibrillation auriculaire: |
206, 378-381; 207, 449; 209, 28-33; 212, 178-181; 225, 369; 256, 340-343; 260, 79; 281, 96-103; 291, 28-29; 292, 17; 293, 23; 306, 8-10; 309, 27-28; 324, 13-14; 333, 11-13; 342, 23-24; 348, 15 |
| Fibrokératome: |
308, 26-27 |
| Fibromyalgie: |
215, 324-333; 279, 37; 316, 14-15 |
| Fibroscan® |
338, 6-10 |
| Fibrose hépatique: |
291, 46-49; 291, 52-54; 338, 6-10; 345, 6-11 |
| Fiche informative: |
276, 332-339 |
|
Fièvre:
– boutonneuse: – jaune: – nue: – prolongée: – typhoïde:
|
215, 357; 216, 406-408; 264, 255; 265, 297; 317, 23-24; 329, 12-14; 338, 19-22; 343, 16-17; 344, 6-11 292, 32-34 298, 26-29 348, 6-14 348, 6-14 298, 26-29 |
| Financement: |
307, 22-28 |
| Fin de vie |
301, 24-28; 304, 42-47 |
| Fissure anale: |
343, 16-17 |
| Fléchisseur profond du doigt: |
200, 69 |
| Flore intestinale: |
324, 17-18 |
| Flutter auriculaire: |
199, 26-29 |
| Focus group: |
292, 38-47 |
| Fonction ovarienne: |
324, 6-9 |
| Foramen ovale: |
296, 40-44 |
Formation: – continue: |
298, 40-42; 299, 40-42; 323, 20-23 200, 70-72; 224, 276-279; 279, 33-35; 293, 36-39; 295, 46-53; 297, 18-20; 302, 16-18; 305, 14-16; 331, 11-13 |
| Formule de Cockroft: |
222, 189-191 |
Fracture: – de stress: – du col fémoral: – du trochiter: |
300, 26-34; 303, 8-17; 304, 8-24; 332, 12-14 221, 112-120; 242, 161 295, 54-60; 326, 11-12; 328, 10-12 266, 325 |
| Fragilité: |
299, 26-32; 309, 6-10 |
| Froid: |
318, 16-17 |
| Frottis cervical: |
206, 397; 222, 176-179; 227, 444-451; 227, 464-468; 250, 64-65; 296, 8-18; 299, 34-39; 300, 26-34; 313, 15-16; 315, 21-24 |
| FSH: |
300, 26-34; 324, 6-9 |
| |
(haut de la page)
|
| Gabapentine: |
299, 18-20 |
| Galactorrhée: |
333, 14-16 |
Gale: – commune: – norvégienne: |
228, 533; 304, 34-41; 322, 19-21 228, 518-521 215, 340-343 |
| Ganglion sentinelle: |
236, 418-419 |
|
Garde:
– de nuit:
|
297, 18-20; 297, 24-32; 299, 18-20; 307, 22-28; 317, 15-16; 346, 15 274, 259-262 |
| Gastrectomie: |
307, 30-45 |
| Gastrite chronique: |
332, 22-23 |
| Gastro-entérite: |
286, 316-321 |
| Gastroparésie: |
309, 14-16 |
| Gastroplastie: |
208, 468-473 |
|
Genou:
– varum/valgum:
|
202, 188-189; 222, 164-173; 226, 417-419; 259, 26-29; 296, 48-55; 322, 19-21 334, 06-09 |
| Gériatrie: |
232, 201; 237, 460-463; 245, 296-297; 262, 150-152; 270, 79; 281, 96-103; 286, 326-329; 294, 24-27; 296, 58-61; 297, 24-32; 300, 22-24; 303, 44-49; 305, 30-38; 307, 22-28; 307, 46-48; 328, 6-9; 334, 10; 336, 22-24; 338, 19-22; 340, 11-13 |
| Gestion des soins: |
295, 22-30; 297, 24-32; 308, 8-10 |
| GHB: |
348, 18-19 |
| Giardia: |
297, 54-56 |
Glande: – mammaire surnuméraire: – sébacée: – sudoripare: |
288, 415 342, 18-19 333, 19-20 |
| Glaucome: |
226, 410-414; 292, 17; 324, 10-12 |
| GLEM: |
199, 16-20, 230, 70-72 |
| Glitazones: |
327, 20-25 |
| Glomérulonéphrite: |
301, 36-44 |
| Glosso-pharyngien: |
201, 132-137 |
| Gluten: |
235, 332-339; 347, 14-15 |
| GNA: |
252, 144-149 |
| Gonalgie: |
312, 23-24; 338, 11-13 |
| Gonarthrose: |
309, 11-12 |
| Goutte: |
246, 353-357; 291, 18; 298, 44-50; 301, 36-44; 303, 18-20; 310, 13-14; 333, 17-18; 344, 12-13 |
| Grains de Fordyce: |
342, 18-19 |
| Granulome: |
316, 16-17 |
| Graves-Basedow |
306, 56-61 |
| Greffe: |
303, 44-49 |
Grippe: – A H1N1: |
265, 297; 277, 405; 325, 6-9; 345, 15-16 267, 366-367 |
|
Grossesse:
– extra-utérine
|
204, 276-277; 234, 276-284; 246, 332-341; 246, 344-346; 269, 08-12; 272, 172-179; 292, 18; 293, 24; 295, 16-21; 299, 34-39; 302, 24-31; 304, 26-28; 305, 8-12; 305, 14-16; 305, 22-28; 316, 14-16; 324, 19-20; 332, 12-14; 334, 21-22; 336, 13-14; 340, 11-13; 342, 13 254, 257; 305, 22-28 |
| Guêpe (piqûre de -): |
230, 93 |
| |
(haut de la page)
|
| Halonaevus: |
297, 22-23 |
| Hamartochondrome: |
330, 23-24 |
Hamartome: – sébacé de Jadassohn: |
330, 23-24 258, 408-414 |
| Hanche: |
316, 26-27 |
| Handicap mental: |
271, 123 |
| Hantavirus: |
281, 116-119; 281, 125 |
| HbCO: |
265, 284-288; 272, 166-170 |
| HBPM: |
201, 122-124; 296, 8-18; 317, 23-24 |
| Hélicobacter pylori: |
229, 41; 292, 50-53; 332, 22-23 |
| Hémangiome infantile: |
300, 22-24; 328, 10-12 |
Hématome: – épidural: – rétro-hyaloïdien: – rétro-péritonéal: – sous-dural: |
240, 73 322, 19-21 234, 297-298 305, 22-28 300, 50-52 |
| Hématurie: |
288, 404-411; 328, 22-23; 347, 14-15 |
| Hémoccult: |
260, 52-59; 309, 11-12 |
| Hémochromatose: |
294, 49-50 |
| Hémoglobine glycosylée: |
279, 8-15; 305, 14-16 |
| Hémoptysie: |
330, 23-24; 343, 23-24 |
| Hémorragie: |
254, 257; 301, 24-28; 316, 18-19 |
| Hémostase: |
274, 271 |
| Héparine: |
294, 46; 306, 8-10; 334, 10 |
Hépatite: – aiguë: – alcoolique: – C:- chronique: – E: – médicamenteuse: – virale: |
273, 229; 277, 405; 281, 116-119; 281, 125 325, 22-23 291, 46-49; 302, 24-31; 318, 23-25 200, 88-89; 205, 312-317; 289, 20-23; 292, 16; 322, 12-13; 345, 6-11 289, 20-23 309, 14-16; 325, 22-23; 338, 11-13 273, 216-221; 340, 23-24 292, 16 |
Hernie: – discale: – hiatale: – inguinale: – ombilicale: – sous-cutanée: |
229, 30-37; 309, 11-12 199, 41; 323, 18-19 305, 22-28 281, 107 335, 15-16 |
Herpès: – circiné: – génital: |
311, 13-14 296, 46-47 |
| HHV8: |
328, 15-16 |
| Hidrosadénite suppurée: |
341, 13-16 |
| HIV: |
250, 56-61; 252, 159; 328, 15-16 |
| HOMA: |
284, 240-241 |
| Homocystéine: |
295, 34-43; 302, 16-18 |
| Hormone parathyroïdienne: |
294, 28-36 |
| Hormonothérapie: |
220, 85-89; 253, 202-209 |
| Hospitalisation: |
262, 150-152 |
| Horton: |
226, 410-414 |
| HPV: |
222, 176-179; 245, 294-295; 300, 26-34; 313, 15-16; 319, 26-27 |
| HTAP: |
259, 35 |
| Hydronéphrose: |
205, 347 |
Hygiène: – buccodentaire – des soins: |
340, 11-13 264, 242-245 |
| Hygroma coude: |
290, 18-19 |
| Hymen: |
245, 315 |
| Hyperactivité: |
238, 496-500 |
| Hypercalcémie: |
292, 18; 294, 28-36 |
| Hypercalciurie: |
288, 404-411; 292, 25 |
Hypercholestérolémie: – familiale: |
297, 24-32; 315, 21-24 332, 22-23 |
| Hypercoagulabilité: |
265, 270-274 |
| Hyperglycémie postprandiale: |
237, 469-472 |
| Hyperhydrose: |
244, 253; 244, 255; 282, 152-157 |
| Hyperkaliémie: |
301, 36-44; 311, 20-22 |
| Hyperkératose: |
215, 340-343 |
| Hyperlipémie postprandiale: |
237, 469-472 |
| Hyperménorrhée: |
294, 50 |
| Hyperoxalurie: |
292, 25 |
| Hyperparathyroïdie: |
292, 18; 338, 19-22 |
| Hyperphagie: |
310, 20-22 |
| Hyperphosphatémie: |
294, 28-36 |
| Hyperprolactinémie: |
333, 14-16; 338, 19-22 |
| Hypersensibilité: |
331, 6-10 |
| Hypersomnie: |
241, 108-113 |
| Hypersplénisme: |
294, 46 |
Hypertension: – artérielle:- oculaire: |
209, 22-23; 209, 24-27; 211, 124-126; 217, 428-434; 225, 344-345; 230, 70-72; 233, 224-228; 243, 223; 260, 79; 281, 96-103; 287, 360-366; 288, 427-431; 299, 26-32; 300, 16-18; 301, 30-35; 316, 14-15; 319, 20-21; 332, 12-14; 334, 17-18; 335, 12-14; 348, 15 292, 17 |
| Hyperthermie: |
216, 406-408; 235, 365; 329, 20-21 |
| Hypertrichose: |
306, 20-23 |
| Hyperthyroïdie: |
282, 169; 292, 8-14; 294, 20-22; 342, 13 |
| Hypertrophie gingivale: |
330, 18-19 |
| Hypertrophie ventriculaire gauche: |
209, 24-27 |
| Hyperuricémie: |
291, 18; 298, 44-50; 301, 36-44; 303, 18-20; 310, 13-14 |
| Hypnotiques: |
244, 240-243 |
| Hypoacousie: |
236, 421 |
| Hypocalcémie: |
294, 28-36 |
| Hypochondre gauche: |
283, 213 |
| Hypocondrie: |
237, 477 |
| Hypodermite nodulaire subaiguë migratrice: |
298, 24-25 |
| Hypofertilité: |
320, 6-16 |
| Hypoglycémie: |
335, 12-14; 336, 13-14 |
| Hypolipidémiants: |
239, 30-35 |
| Hypomélanose idiopathique en gouttes: |
286, 325 |
| Hyponatrémie: |
257, 364-369; 275, 317; 296, 58-61; 330, 16-17 |
| Hypophosphatémie: |
294, 28-36 |
| Hypopigmentation maculaire: |
286, 325 |
| Hypoplasie mammaire: |
301, 20-21 |
| Hyposialie: |
324, 17-18 |
| Hypotension: |
287, 393; 305, 22-28; 310, 13-14 |
| Hypothyroïdie: |
292, 8-14; 306, 56-61; 331, 11-13 |
| Hystérie: |
268, 402-406 |
| |
(haut de la page)
|
| Iatrogénicité: |
239, 43; 247, 407; 258, 435; 273, 229; 279, 37; 287, 393; 288, 439; 310, 13-14; 311, 20-22; 322, 14-15; 324, 21-22; 330, 16-17; 332, 17-21; 335, 12-14; 338, 14-15; 340, 23-24 |
| Ictère: |
318, 23-25 |
| Ictus amnésique: |
313, 19-21 |
| IEC: |
332, 12-14 |
IgA: – anti-endomysium: – anti-transglutaminase: |
235, 332-339 235, 332-339 |
| Iléocolite: |
294, 45 |
| Imagerie médicale: |
293, 29-35; 312, 23-24; 319, 22-23; 323, 6-11 |
| Immigration: |
297, 24-32 |
| Immunomodulateurs: |
217, 438-440 |
| Immunosuppresseurs: |
337, 19-20 |
| Immunothérapie: |
333, 21-22; 337, 19-20 |
Impétigo: – bulleux: |
322, 19-21; 346, 16-17 214, 288-291 |
| Impuissance: |
315, 12-13 |
| Implant cochléaire: |
231, 128-131 |
| Implant hormonal: |
299, 34-39 |
| Incapacité professionnelle: |
290, 14-16; 302, 42-44 |
| Incertitude: |
315, 21-24; 336, 22-24 |
| Incidentalome: |
333, 14-16 |
| Incision: |
203, 208-212 |
| Inconscient: |
226, 398-399 |
Incontinence: – anale: – urinaire: |
264, 239 219, 28-34; 292, 25-27; 302, 8-15 |
| Incrétines: |
266, 328-333 |
| Incrétinomimétiques: |
327, 20-25 |
| Indigence: |
296, 8-18 |
| Industrie pharmaceutique: |
297, 18-20 |
| Inégalités sociales: |
276, 348-351; 323, 20-23; 324, 13-14; 331, 19-20 |
| Inertie thérapeutique: |
299, 26-32 |
|
Infarctus:
– omental: – rénal: – splénique:
|
204, 293; 205, 243-344; 232, 186-189; 285, 300-301; 316, 18-19; 324, 13-14 284, 255 283, 213 309, 27-28 |
Infection: – fongique: – nosocomiale: – respiratoire:- urinaire: |
300, 16-18; 307, 22-28 344, 14-15 264, 242-245 291, 17; 301, 24-28; 307, 22-28; 313, 15-16; 340, 11-13 240, 91; 265, 297; 292, 23-24 |
|
Infiltration:
– intra-articulaire:
|
199, 23; 204, 291; 227, 475-479 229, 30-37; 305, 22-28 335, 20-21 |
| Inflammation: |
294, 45-46 |
| Informatique médicale: |
210, 89-91; 240, 84-89; 249, 16-17; 333, 11-13 |
| Infraction: |
338, 19-22 |
| Inhalation sèche: |
199, 8-12 |
Inhibiteurs : – calciques: – de la pompe à protons: – de l’enzyme de conversion: |
311, 11-12; 312, 13-14 voir IPP voir IEC |
| Injection intramusculaire: |
342, 14-17 |
| INR: |
293, 8-20 |
| Insecte: |
220, 74-77 |
| Insomnie: |
241, 108-113; 244, 240-243; 294, 16-17; 294, 18; 304, 34-41; 327, 6-15; 331, 16-18; 344, 16-18 |
| Institutionnalisation des personnes âgées: |
255, 295-297 |
| Insuffisance cardiaque: |
224, 282-285; 225, 369; 243, 212-217; 280, 78-79; 295, 54-60; 298, 20-23; 306, 24-32; 345, 12 |
| Insuffisance hépatique: |
291, 46-49 |
|
Insuffisance rénale:
– aiguë: – chronique:
|
291, 46-49; 292, 24-25; 301, 36-44; 311, 20-22; 329, 17-19; 335, 12-14; 343, 6-15 281, 116-119; 281, 125; 302, 16-18; 304, 26-28 283, 200-203; 292, 28-29 ; 310, 6-12; 335, 6-11 |
| Insuffisance veineuse: |
303, 26-31 |
| Insuline: |
244, 258-263; 270, 67-69; 312, 6-12 |
| Insulinorésistance: |
237, 469-472; 284, 240-241 |
| Insulinothérapie: |
338, 19-22 |
| Interaction médicamenteuse: |
303, 18-20; 304, 34-41; 307, 8-10; 329, 17-19; 330, 16-17 |
| Interféron: |
205, 312-317 |
| Intertrigo: |
218, 494-497 |
Intervention: – brève: – de crise: – précoce: |
302, 16-18; 314, 23-24; 317, 19-20; 347, 18-19 300, 8-15 340, 6-10 |
| Intolérance glucidique: |
310, 13-14 |
| Intoxication alimentaire: |
274, 270; 335, 22-23 |
| Intuition: |
310, 26-27; 338, 6-11 |
| IPP: |
222, 184-186; 263, 201-205; 318, 16-17; 332, 12-14 |
| Iris: |
305, 18-19 |
| Irradiation: |
205, 332-336; 319, 22-23; 341, 13-16 |
| Irritation: |
284, 237 |
| Ivermectine: |
215, 340-343 |
| IVG: |
269, 08-12 |
| |
(haut de la page)
|
| Jeunes: |
340, 6-10 |
| Juge de paix: |
344, 16-18 |
| |
(haut de la page)
|
| Kaliémie: |
292, 28-29; 341, 19-22 |
| Kawasaki: |
338, 19-22 |
| Kératoacanthome: |
285, 281 |
Kératose: – actinique: |
236, 406-412 289, 8-19 |
| Kératolyse ponctuée plantaire: |
244, 253 |
Kinésithérapie: – respiratoire: |
241, 118-120 194, 248-252 |
Kyste: – arthro-synovial: – articulaire: – mucineux: – mucoïde: – poplité: |
204, 291 307, 20-21 255, 285 277, 387 259, 26-29; 309, 13 |
| |
|
| Laminectomie: |
305, 22-28 |
| Langage: |
231, 112-117; 231, 128-131 |
Larmoiement: – chronique: |
289, 20-23 254, 243 |
| Larynx: |
210, 72-73 |
| LDH: |
283, 213 |
| LDL-cholestérol: |
335, 20-21 |
| L-Dopa: |
217, 448-453 |
| Lecture critique: |
262, 140-145 |
| Légionellose: |
277, 401; 281, 122-123 |
| Legg-Calvé-Perthès: |
229, 22-25 |
| Leiomyosarcome: |
293, 26-27 |
| Leishmaniose: |
291, 32-35 |
| Lentigo malin: |
324, 15-16 |
| Lentilles de contact: |
311, 23-25 |
| Leptospirose: |
347, 14-15 |
Lésion: – abdominale: – conjonctivale: – érythémateuse: – inflammatoire: |
293, 34 318, 18-19 263, 197 291, 32-35 |
| Leucocytose: |
294, 46 |
| Leucopénie: |
294, 48 |
| Lévothyroxine: |
331, 11-13 |
| Lèvres: |
342, 18-19 |
| Lichen striatus: |
200, 78-81; 337, 12-13 |
| Lichenification: |
284, 237 |
Ligament: – croisé postérieur: – latéral externe: – latéral interne: – scapho-lunaire: – triangulaire du poignet: |
296, 48-55 214, 272-277 296, 48-55 296, 48-55 296, 48-55 |
Ligne: – de Blaschko: – de tension: |
337, 12-13 203, 208-212 |
| Linea nigra: |
345, 13-14 |
| Lipome: |
269, 19 |
Lithiase: – rénale: – salivaire: – urinaire: |
313, 15-16 267, 369 292, 25 |
| Lithium: |
307, 8-10 |
| Lombalgie: |
217, 444-447; 226, 425; 245, 307-309; 264, 228-232; 277, 392-397; 293, 31; 293, 33-34; 305, 22-28; 306, 34-41; 311, 11-12; 312, 13-14; 312, 23-24; 313, 15-16; 317, 21-22; 326, 11-12; 332, 22-23 |
| Lupus: |
288, 439; 295, 34-43; 333, 11-13; 333, 17-18 |
Luxation: – congénitale de la hanche: – de la rotule: – des tendons péroniers: – gléno-humérale: |
308, 30-33 222, 164-173; 223, 220-228 224, 294-297 296, 48-55 |
| Lymphœdème: |
296, 8-18; 338, 17-19 |
| Lymphome non hodgkinien: |
250, 83; 344, 19-20 |
| |
(haut de la page)
|
| Macrocytose: |
236, 384-391 |
| Macula: |
226, 388-392 |
| Maculopathie liée à l’âge: |
311, 23-25 |
Magistrales: Acné rosacée: Gale: Hyperhydrose plantaire: |
220, 67 228, 533 244, 255 |
| Magnésémie: |
341, 19-22 |
| Maison de repos: |
218, 480-485; 245, 296-297; 306, 44-48; 322, 6-11 |
| Maison médicale: |
334, 17-18 |
| Mal aigu des montagnes: |
284, 244-253 |
| Mal de gorge: |
211, 145; 252, 144-149 |
| Mal des transports: |
338, 11-13 |
| Maladie à déclaration obligatoire: |
274, 266-267; 304, 48-52 |
| Maladie auto-immune: |
295, 34-43 |
| Maladie chronique: |
214, 302-304; 321, 19-20 |
| Maladie cœliaque: |
200, 60-64; 209, 41; 235, 332-339; 268, 429; 332, 22-23 |
| Maladie coronaire: |
345, 12 |
| Maladie de Basedow: |
294, 20-22; 341, 13-16; 342, 13 |
| Maladie de Crohn: |
308, 12-24; 324, 13-14; 348, 22-23 |
| Maladie de Horton: |
275, 304-306; 341, 23-24 |
| Maladie de Ledderhose: |
247, 395 |
| Maladie de Lyme: |
248, 453; 274, 255; 284, 228-233; 325, 10; 330, 20-22; 337, 14-15; 338, 11-13 |
| Maladie de Ménière: |
318, 06-15 |
| Maladie de Mordor: |
327, 18-19 |
| Maladie des griffes du chat: |
251, 127 |
| Maladie de Verneuil: |
306, 50-55; 341, 13-16 |
| Maladie de Waldenström: |
294, 8-14; 344, 19-20 |
| Maladie thrombo-embolique: |
237, 477; 265, 270-274 |
| Maladie infectieuse: |
298, 32-38 |
| Maladie inflammatoire intestinale: |
308, 12-24 |
| Maladie tropicale: |
344, 6-11 |
| Malaise vagal: |
252, 169 |
| Malaria: |
244, 267; 298, 26-29; 317, 23-24; 329, 17-19 |
| Malformation d’Arnold-Chiari: |
298, 52-54 |
| Malformation rénale: |
205, 347 |
| Mallet finger: |
260, 63 |
| Malnutrition: |
289, 44-47; 294, 45; 295, 54-60 |
| Malposition dentaire: |
338, 12-13 |
| Mammographie: |
306, 12-19 |
| Mammotest: |
218, 509; 219, 21; 221, 121; 222, 195; 224, 291; 226, 421-423; 254, 244-245; 308, 8-10 |
| Manie: |
282, 140-145 |
| MAPA (Mesure Ambulatoire de la Pression Artérielle): |
233, 224-228; 299, 26-32 |
Marqueurs: – biologiques: – osseux: |
205, 243-344 213, 236-238 |
| Mastalgie: |
269, 28-30 |
| Mastectomie: |
314, 15-16 |
| Mastocytose: |
304, 34-41 |
| Mastodynie: |
269, 28-30; 299, 34-39 |
| MDRD2: |
283, 200-203 |
| Médecin: |
238, 526-527; 306, 24-32; 336, 6-12 |
| Médecine de première ligne: |
330, 20-22 |
| Médecine du sport: |
213, 244-246; 214, 272-277; 224, 294-297; 228, 500-507; 240, 74-80; 269, 32-33; 271, 117; 292, 19 |
| Médecine du travail: |
302, 42-44; 329, 6-11 |
| Médecine générale: |
252, 154-156; 255, 289-291; 260, 70-73; 310, 13-14; 335, 12-14 |
| Médecine légale: |
273, 200-207 |
| Médecine préventive: |
202, 164-166; 266, 336-337; 266, 338-340 |
| Médecins vigies: |
219, 17-18; 287, 384-386 |
| Médicaments: |
231, 120-123; 297, 24-32; 303, 26-31; 309, 23-24; 318, 16-17 |
| Mégalérythème: |
233, 240-243; 348, 16-17 |
|
Mélanome:
– épidermique:
|
202, 170-172; 297, 24-32; 300, 16-18; 318, 18-19; 323, 20-23; 334, 19-20; 338, 20-24 324, 15-16 |
| Mélanose de Dubreuilh: |
324, 15-16 |
| Mélatonine: |
344, 16-18 |
| Membrane d’Hassner: |
254, 243 |
| Mémoire: |
309, 17-22; 340, 16-17 |
| Ménarche: |
245, 284-291 |
| Méningisme: |
244, 267 |
| Méningite: |
278, 447; 298, 26-29; 338, 19-22 |
| Méningocoque: |
244, 246-247 |
| Ménisque: |
222, 164-173; 226, 417-419; 309, 11-12 |
| Ménopause: |
207, 424-428; 240, 64-69; 291, 26-27; 300, 26-34; 311, 11-12; 312, 13-14; 324, 6-9 |
| Ménorragie: |
294, 50 |
| Méralgie paresthésique: |
265, 295-296 |
| Mesh: |
297, 34-46 |
| Message: |
199, 38-39 |
| Métatarsiens: |
221, 112-120 |
| Metformine: |
327, 20-25 |
| Méthadone: |
204, 282-287; 267, 358-362 |
| Méthode PRC: |
200, 88-89 |
| Méthotrexate: |
271, 96-105; 296, 40-44; 328, 10-12; 332, 22-23 |
| Méthylphénidate: |
238, 496-500 |
| Métrorragie: |
206, 397 |
| MGUS: |
294, 8-14 |
| MICI: |
348, 22-23 |
| Microalbuminurie: |
288, 404-411 |
| Microchirurgie: |
201, 132-137 |
| Micro-ondes: |
270, 52-59 |
| Microparticules: |
317, 23-24 |
| Mictalgies: |
213, 253 |
| Migraine: |
285, 272-277; 303, 44-49; 307, 8-10; 313, 19-21; 322, 12-13; 324, 10-12; 326, 23-24; 332, 6-11 |
| Milieu rural: |
324, 19-20 |
| Mirtazapine: |
294, 17 |
| Mise en observation: |
278, 420-427; 331, 16-18; 343, 20 |
| Mise sous protection: |
343, 20 |
| Mobilophonie: |
270, 52-59 |
| Mode de vie: |
238, 504-505 |
| Modèles d’organisation des soins de santé: |
295, 22-30 |
| Molluscum contagiosum: |
260, 66-67; 329, 12-14 |
| Mono-arthrite: |
246, 353-357; 310, 15-16; 334, 11-12 |
| Mononucléose: |
211, 145; 248, 453; 290, 52-53 |
| Monoxyde de carbone: |
265, 284-288, 272, 166-170 |
| Morphine: |
279, 20-21; 290, 44-45; 320, 17 |
| Morpions: |
341, 13-16 |
Mort: – naturelle/suspecte: – subite: |
230, 64-67; 303, 44-49 225, 332-341 + addenda 248, 435; 290, 26-29; 316, 6-13; 324, 10-12 |
Mortalité: – fœto-maternelle: – périnatale: |
246, 332-341 329, 12-14 |
| Motivation: |
298, 40-42; 299, 40-42; 299, 44-47 |
| MRSA: |
218, 480-485; 322, 6-11 |
| MST: |
228, 518-521; 290, 48-51; 299, 34-39; 315, 21-24 |
| Mucolytique: |
307, 22-28 |
| Multimorbidité: |
325, 10; 336, 22-24; 340, 11-13 |
| Muscle soléaire accessoire: |
317, 17-18 |
| Musicien: |
238, 512-521 |
| Mutation BRCA2: |
314, 15-16 |
| Myasthénie: |
291, 38-44 |
| Mycobactérie: |
316, 16-17 |
| Mycoplasma pneumoniae: |
211, 145; 251, 111; 299, 50-52; 329, 20-21 |
| Mydriase: |
273, 211 |
| Myélome: |
294, 8-14 |
| Myocardite: |
302, 46-49 |
| Myopathie: |
290, 14-16; 322, 12-13 |
| Myopie: |
226, 388-392 |
| Myorelaxants: |
306, 34-41 |
| Mytilisme: |
335, 22-23 |
| |
(haut de la page)
|
Nævus: – bénin: – bleu: – de Becker: – de Sutton: – sébacé: – spilus: |
340, 14-15 340, 14-15 306, 20-23 297, 22-23 258, 408-414; 302, 20-21 306, 20-23 |
| Nalméfène: |
313, 24-25; 314, 6-14 |
| Naltrexone: |
293, 47 |
| Narcolepsie: |
292, 54-55 |
| NASH: |
225, 356-360; 324, 17-18 |
| Nébuliseur humide: |
199, 8-12 |
| Nécrobiose lipoïdique: |
211, 128-131 |
| Négociation: |
212, 173-175 |
| Néoplasie intestinale: |
200, 91 |
Néphrite: – interstitielle: |
281, 125 255, 303; 329, 17-19 |
| Néphropathie: |
213, 216-222 |
Nerf: – facial: – fémoro-cutané: – optique: – pudendal: – radial: |
313, 17-18 265, 295-296 324, 10-12 264, 250-251 338, 17-18 |
| Neuroborréliose: |
285, 309 |
| Neurofibromatose: |
317, 21-22 |
| Neurofibrome: |
222, 201 |
| Neuro-imagerie: |
347, 18-19 |
| Neuroleptiques: |
229, 8-15; 242, 168-174; 317, 19-20; 343, 16-17 |
| Neuronite vestibulaire: |
318, 06-15 |
| Neuropathie: |
254, 248-255; 341, 13-16 |
| Neuropsychologie: |
340, 16-17 |
| Neutropénie: |
235, 365; 253, 202-209; 296, 40-44 |
Névralgie: – d’Alcock: – du trijumeau: |
201, 132-137 264, 250-251 313, 19-21 |
| Névrodermite: |
284, 237 |
| Nicotine: |
232, 178-180; 251, 112-115; 272, 152-154; 272, 162-165; 295, 16-21 |
| NNT: |
217, 455-457 |
Nodule: – cutané: – d’hyperplasie fibro-épithéliale: – pulmonaire – thyroïdien: |
247, 395 338, 12-13 201, 126-129; 235, 347-348; 236, 395-396; 275, 299 300, 40-46 220, 80-82 |
| Normes de soins: |
296, 8-18 |
| Norovirus: |
286, 316-321 |
| Notice: |
318, 16-17 |
| Nourrisson: |
228, 522-526; 323, 20-23 |
| Noyade: |
317, 15-16 |
| NT-pro-BNP: |
280, 78-79 |
| Nutrition: |
245, 296-297; 310, 20-22; 317, 15-16; 329, 12-14; 347, 14-15 |
| Nystagmus: |
233, 248-254 |
| |
(haut de la page)
|
| Obésité: |
208, 468-473; 220, 60-66; 303, 44-49; 307, 12-19; 307, 30-45; 309, 23-24; 310, 20-22; 324, 17-18; 326, 15-17; 338, 17-19; 348, 20-21 |
| Observance: |
200, 82-84 |
| Occlusion intestinale: |
257, 391; 304, 42-47 |
Œdème: – cérébral d’altitude: – de Quincke: – pulmonaire aigu: – pulmonaire d’altitude: |
202, 191; 295, 54-60; 299, 34-39; 318, 26-27 284, 244-253 230, 93 316, 18-19 284, 244-253 |
| Œil: |
228, 528-530 |
| Œsophage de Barrett: |
263, 201-205; 291, 18 |
Œsophagite: – de reflux: |
222, 184-186; 343, 23-24 212, 197 |
| Œstrogènothérapie substitutive: |
291, 27-28 |
| Œstroprogestatifs: |
207, 424-428 |
| Omarthrose: |
303, 26-31 |
| Omoplate: |
269, 32-33 |
| Oncologie: |
236, 418-419 |
| Ondansétron: |
293, 47-48 |
| Ongle: |
295, 32-33; 300, 22-24; 343, 18-19 |
| Onychodystrophie: |
310, 15-16; 343, 18-19 |
| Onychomycose: |
300, 22-24; 314, 15-16; 338, 20-24; 344, 14-15 |
| Ophtalmologie: |
311, 23-25 |
| Opioïdes: |
290, 32-41; 294, 18 |
| Orchidopexie: |
247, 380-385 |
| Oreillons: |
293, 54-57; 304, 48-52 |
| Orf: |
201, 126-129; 275, 299; 321, 13-14 |
Organisation: – de la pratique: – des soins: |
299, 18-20; 323, 20-23; 340, 11-13; 344, 22-23 307, 22-28; 311, 11-12; 312, 13-14; 321, 19-20; 334, 17-18; 335, 12-14; 336, 22-24; 346, 15 |
| Orgasme féminin: |
211, 142-143 |
| Orgelet: |
311, 23-25 |
| Orthostatisme: |
211, 134-140 |
| Oseltamivir: |
267, 366-367 |
| Ostéochondrite: |
239, 8-15 |
| Ostéonécrose: |
324, 19-20 |
| Ostéoporose: |
213, 236-238; 214, 292-294; 286, 326-329; 293, 24; 298, 44-50; 300, 26-34; 303, 8-17; 303, 44-49; 304, 8-24; 324, 19-20; 327, 16-17; 340, 11-13 |
Otite: – externe: – moyenne: – moyenne aiguë: |
318, 16-17; 337, 11 331, 11-13 202, 178-180 |
| Otorrhée: |
209, 8-12 |
| Oubli: |
213, 226-227; 319, 20-21 |
| Outils de communication: |
243, 202-203 |
| Ovarite: |
219, 41 |
| Ovidés: |
201, 126-129 |
Oxygénothérapie: – hyperbare: |
291, 23-24 303, 26-31 |
| Oxymétrie: |
249, 24-28 |
| |
(haut de la page)
|
| Pacemaker: |
325, 20-21; 336, 17-18 |
| Palpitations: |
199, 41; 212, 178-181; 265, 281 |
| Paludisme: |
298, 26-29 |
| Panaris: |
314, 17-18 |
| Pandémie: |
267, 366-367 |
| Panniculite a frigore: |
298, 24-25 |
| Pansements hydrocolloïdaux: |
294, 25; 295, 54-60 |
| Papillomavirus: |
voir HPV |
Papules: – blanches: – perlées péniennes: – piézogéniques: |
336, 15-16 333, 19-20 329, 15-16 335, 15-16 |
| Papulose lymphomatoïde: |
236, 395-396 |
| Paracétamol: |
304, 26-28; 326, 11-12 |
| Paralysie faciale: |
285, 309; 290, 52-53 |
| Paranoïa: |
264, 241 |
| Paraphénylènediamine (PPD): |
253, 199 |
| Parapoxvirus: |
321, 13-14 |
| Paraprotéinémie: |
294, 8-14; 344, 19-20 |
| Parasomnie: |
241, 108-113 |
| Paresthésies: |
267, 385 |
| Parkinson: |
217, 448-453; 224, 313; 242, 179; 329, 12-14 |
| Parotide: |
256, 329 |
| Parotidite: |
293, 54-57; 304, 48-52 |
| Partage des données: |
206, 390-393 |
| Parvovirus: |
233, 240-243; 348, 16-17 |
Pathologie: – cardiovasculaire: – iatrogène: |
227, 454-456 329, 17-19 |
| Patient borderline: |
207, 416-420 |
| Pauvreté: |
305, 46-49; 334, 13-15 |
| PCSK9: |
335, 20-21 |
| Pédagogie: |
316, 14-15 |
| Pédiatrie: |
208, 484-485; 301, 24-28; 307, 22-28; 329, 12-14 |
| Pédiculose: |
341, 13-16 |
| Pelade: |
219, 35-38; 222, 180-183 |
| Pemphigus: |
322, 14-15 |
| Pénicilline: |
234, 302-309 |
| Peptide B natriurétique: |
224, 282-285 |
Perforation: – du globe oculaire: – utérine: |
203, 229-235 345, 22-24 |
| Péricardite: |
261, 107; 302, 46-49 |
| Périménoppause: |
291, 24-25 |
| Périnéologie: |
219, 28-34 |
| Périonyx: |
202, 174-177 |
| Périonyxis: |
314, 17-18 |
| Péritrochantérite: |
243, 196-199 |
| Permanence des soins: |
297, 24-32 |
| Péroné: |
221, 112-120 |
| Personnalité borderline: |
280, 68-71; 305, 22-28; 318, 20-22; 321, 21 |
| Personne âgée: |
281, 96-103; 286, 326-329; 289, 34-41; 309, 6-10; 317, 19-20; 318, 20-22; 319, 20-21; 322, 6-11; 322, 12-13; 328, 6-9 |
Perte: – de conscience: – de vision: |
240, 91 311, 23-25 |
| Perte de poids: |
268, 429 |
| Perturbateurs endocriniens: |
348, 20-21 |
| Pervers narcissique: |
202, 156-160 |
| Perversion morale: |
202, 156-160 |
| Pharmacovigilance: |
255, 276-281; 297, 24-32; 298, 44-50; 302, 32-40; 338, 19-22 |
| Pharyngite: |
252, 144-149 |
| Pharynx: |
210, 66-67 |
| Phlébite: |
293, 24 |
Photothérapie: – dynamique: |
236, 406-412 289, 8-19 |
| Phtalates: |
348, 20-21 |
| Phyto-œstrogènes |
311, 11-12; 312, 13-14 |
| Phytostérols: |
297, 24-32 |
| Phytothérapie: |
247, 388-393 |
Pied: – d’athlète: – diabétique: – plat, creux: |
328, 13-14 250, 67 213, 216-222 248, 420-427; 322, 19-21 |
| Pigmentation bénigne anormale: |
345, 13-14 |
| Pinguécula: |
292, 20-21 |
| Piscine: |
274, 244-251 |
| Placebo: |
290, 14-16; 347, 18-19 |
| Plaie: |
203, 208-212; 295, 54-60; 303, 18-20; 307, 22-28; 312, 15-16 |
| Plaisir sexuel: |
211, 142-143 |
| Plan de soins: |
336, 22-24 |
| Planning familial: |
269, 08-12 |
| Plaquettes: |
306, 8-10; 317, 23-24 |
| Pleurs: |
290, 14-16 |
| Plexus brachial: |
222, 201 |
| Plombémie: |
211, 122-123 |
| Pneumocoque: |
244, 246-247; 298, 26-29; 310, 23-25; 341, 13-16 |
| Pneumologie: |
301, 24-28 |
| Pneumonie: |
234, 313; 249, 35; 298, 26-29; 300, 40-46; 310, 23-25; 313, 15-16; 341, 13-16; 347, 14-15 |
Pneumopathie: – infectieuse: |
300, 40-46; 329, 20-21; 332, 17-21 301, 24-28 |
| Pneumothorax: |
297, 8-16 |
Poids: – corporel: – de naissance: |
289, 20-23 246, 332-341 |
| Politique de santé: |
314, 23-24 |
Pollution: – intérieure: |
211, 122-123; 333, 11-13 318, 20-22 |
| Polyarthralgies: |
328, 22-23 |
| Polyarthrite rhumatoïde: |
271, 96-105; 295, 34-43; 298, 44-50; 313, 15-16; 332, 22-23; 333, 11-13; 333, 17-18 |
| Polyconsommation: |
348, 18-19 |
| Polymastie: |
288, 415 |
| Polymédication: |
200, 82-84; 294, 24; 336, 22-24 |
| Polymyalgie rhumatismale (PMR): |
333, 17-18 |
| Polynévrite: |
314, 25-26 |
| Polypose colique: |
260, 52-59 |
| Polythélie: |
288, 415 |
Ponction: – articulaire: |
204, 291 202, 188-189; 259, 26-29 |
| Porphyrie: |
328, 22-23 |
| Posologie: |
335, 6-11 |
| Pouce: |
296, 48-55 |
| Poussée tentionnelle: |
223, 257 |
| Poux: |
341, 13-16 |
| Poxvirus: |
275, 299 |
| Pratique professionnelle: |
297, 24-32 |
| Préalbumine: |
294, 45 |
| Précarité: |
278, 432-433; 312, 15-16; 324, 13-14; 331, 19-20; 334, 13-15 |
| Prégabaline: |
346, 15 |
Prélèvement: – sanguin: – post-mortem |
256, 320-325; 294, 44-45 273, 200-207 |
| Prématurité: |
246, 332-341 |
| Prémédication: |
210, 66-67 |
Prescription: – appropriée: – électronique: – inappropriée: |
318, 16-17; 334, 17-18; 336, 22-24 319, 20-21 317, 23-24 305, 30-38; 328, 6-9 |
Pression: – artérielle: – veineuse: |
279, 25-30; 288, 427-431 303, 26-31 |
|
Prévention:
– cardiovasculaire:
– primaire: – quaternaire: – secondaire:
|
207, 436-445; 212, 164-169; 215, 336-337; 242, 163-165; 251, 122-123; 297, 24-32; 298, 32-38; 308, 40-51; 309, 6-10; 313, 15-16; 313, 22-23; 314, 23-24; 317, 15-16; 344, 22-23; 346, 15 248, 448-449; 275, 288-295; 281, 96-103; 302, 16-18; 348, 15 301, 8-15; 315, 21-24; 333, 11-13 342, 20-22 233, 244-246; 340, 18 |
| Prise de poids: |
289, 20-23 |
| Probiotiques: |
253, 188-195 |
| Professionnalisme: |
306, 24-32 |
| Projet thérapeutique: |
338, 19-22; 340, 11-13; 340, 18 |
| Prolapsus rectal: |
257, 373 |
| Promotion de la santé: |
242, 163-165; 255, 289-291; 278, 432-433; 325, 15-19 |
| Propythiouracile: |
304, 30-31 |
| Prostate: |
293, 23 |
| Prostatite: |
292, 23-24 |
| Protéinurie: |
288, 404-411; 292, 28-29; 301, 36-44; 343, 6-15 |
Prothèse: – d’épaule – de genou: – de hanche: – discale: |
303, 26-31 241, 118-120 268, 416-425 267, 378-383 |
|
Prurit:
– anal:
|
200, 78-81; 213, 253; 215, 340-343; 227, 481; 246, 349; 278, 431; 284, 237; 304, 34-41; 319, 26-27; 333, 21-22 341, 17-18 |
| PSA: |
292, 29-30; 293, 22; 296, 40-44; 315, 16-20; 321, 19-20 |
| Pseudo-polyarthrite rhizomélique |
270, 79; 275, 304-306 |
| Pseudo-sciatalgie: |
274, 271 |
|
Psoriasis:
– en gouttes:
|
217, 438-440; 243, 209; 287, 371; 334, 11-12; 338, 20-24 338, 14-15 |
| Psychiatrie: |
323, 20-23 |
| Psychogériatrie: |
344, 16-18 |
| Psychose: |
264, 241 |
| Psychosomatique: |
214, 311 |
| Psychothérapie: |
207, 416-420; 219, 8-13; 309, 11-12; 316, 20-22; 347, 18-19 |
| Psychotropes: |
344, 16-18 |
| Ptérygion: |
292, 20-21; 325, 11-12 |
| Ptosis de la paupière: |
299, 22-24 |
| Puberté (tardive, précoce): |
245, 284-291; 337, 19-20 |
| Publication médicale: |
291, 19 |
| Pulsions: |
226, 398-399 |
Purpura: – d’Henoch-Schönlein: |
218, 511; 304, 30-31 323, 14-15; 336, 19-21 |
| Pustulose faciale: |
331, 14-15 |
| Pyélonéphrite: |
205, 347; 226, 425; 243, 223; 253, 215; 292, 23-24 |
| Pyrosis: |
332, 12-14 |
| Pytiriasis capitis: |
219, 35-38 |
| |
(haut de la page)
|
| QT long: |
319, 6-15 |
| Qualité des soins: |
224, 276-279; 260, 70-73; 281, 108-109; 289, 20-23; 295, 22-30; 314, 21-22; 321, 19-20; 323, 20-23; 328, 10-12; 331, 11-13; 333, 11-13 |
| Qualité de vie: |
245, 296-297; 305, 46-49 |
| Questionnaire DN4: |
247, 400-405 |
| Queue de cheval: |
217, 459 |
| Quinolone: |
239, 43 |
| |
|
| RAA: |
252, 144-149 |
| Radioactivité: |
296, 20-37 |
| Radiofréquences: |
270, 52-59 |
Radiographie: – du thorax: |
305, 22-28 300, 40-46 |
| Radiologie: |
319, 22-23 |
| Radiothérapie: |
315, 12-13 |
| Rage: |
298, 26-29 |
| Raisonnement clinique: |
338, 6-11 |
| Rapport de vraisemblance positif: |
329, 17-19 |
Rayonnements: – ionisants: |
293, 29 296, 20-37; 323, 6-11 |
| Réanimation cardio-pulmonaire: |
221, 132-139 |
| Récepteurs GABA-B: |
293, 47-49 |
Recherche: – documentaire: – qualitative: |
297, 34-46; 301, 8-15 280, 52-56; 292, 38-47 |
| Récolte de données: |
235, 343-344; 240, 84-89; 254, 232-237 |
| Recommandations de bonne pratique: |
200, 70-72; 202, 178-180; 204, 260-264; 212, 184-186; 250, 78-80; 256, 332-337; 272, 152-154; 272, 156-159; 277, 392-397; 279, 8-15; 279, 25-30; 297, 18-20; 297, 24-32; 306, 24-32; 323, 16-17; 348, 20-21 |
| Récompense: |
299, 44-47 |
Rectocolite: – ulcéro-hémorragique: |
304, 26-28; 308, 12-24 324, 13-14; 348, 22-23 |
| Rectorragie: |
348, 22-23 |
| Rectosigmoïdoscopie: |
299, 18-20 |
| Réduction de la consommation (d’alcool): |
313, 24-25; 314, 6-14 |
| Réflexion sur l’évolution de la MG: |
252, 154-156 |
| Reflux gastro-œsophagien: |
222, 184-186; 263, 201-205; 308, 30-33; 309, 14-16; 318, 16-17; 332, 12-14 |
| Régime: |
310, 20-22 |
| Réhabilitation cognitive: |
348, 18-19 |
| Rein: |
301, 30-35 |
| Relation médecin/patient: |
226, 398-399; 234, 293-294; 238, 526-527; 291, 56-58; 297, 18-20; 300, 36-38; 305, 46-49; 307, 46-48; 308, 8-10; 309, 25-26; 315, 21-24; 330, 20-22; 331, 19-20; 334, 13-15; 334, 17-18; 344, 22-23 |
| Remboursement: |
239, 30-35; 256, 332-337 |
| Remplacement valvulaire cardiaque: |
296, 40-44 |
| Renforcement excentrique: |
240, 74-80 |
Repérage: – précoce: |
323, 16-17 314, 23-24 |
| Repli conjonctival: |
340, 19-20 |
| Représentation de la maladie: |
208, 476-479 |
| Réseau: |
310, 20-22 |
| Résilience: |
219, 8-13 |
| Responsabilité sociale: |
335, 17-19 |
| Resurfaçage: |
335, 20-21 |
| Retraite: |
344, 22-23 |
| Rhinite: |
338, 14-16 |
Rhumatisme: – inflammatoire des ceintures: – psoriasique: |
298, 44-50 310, 15-16 |
| Rhumatologie: |
231, 124-127; 333, 11-13 |
| Rhume de hanche: |
308, 30-33 |
| Rickettsia: |
292, 32-34 |
Risque: – absolu / relatif: – cardiovasculaire:- chirurgical: – nucléaire: – psychosocial: |
217, 455-457 212, 164-169; 233, 244-246; 236, 395-396; 237, 451-452; 238, 504-505; 240, 64-69; 243, 202-203; 248, 448-449; 256, 332-337; 287, 360-366; 298, 20-23; 322, 22-24; 335, 12-14; 338, 11-13; 340, 18 338, 11-13 296, 20-37 329, 6-11 |
| Rituximab: |
250, 83 |
| RMN: |
309, 11-12 |
| Ronflement: |
257, 376-383 |
| Rosacée: |
309, 14-16; 332, 12-14 |
| Rotation: |
190, 76-81 |
| Rotavirus: |
235, 361-363; 244, 246-247; 300, 16-18 |
| Rotule: |
226, 417-419; 331, 11-13 |
| Rougeole: |
288, 434-437 |
| Rubéole: |
241, 117 |
| Rupture d’anévrysme: |
301, 16-18 |
| Rupture tendineuse: |
279, 19 |
| |
(haut de la page)
|
| Salpingite: |
290, 48-51 |
Santé: – du médecin: – environnementale: – mentale: – publique: – subjective: |
316, 14-15 318, 20-22 251, 122-123 215, 346-352; 314, 15-16; 323, 20-23 235, 350-355; 298, 32-38; 334, 13-15 310, 17-19 |
| Sarcoïdose: |
210, 76-79; 327, 26-27; 346, 23-24 |
| Sarcome de Kaposi: |
328, 15-16 |
| Sarcopénie: |
289, 34-41; 295, 54-60 |
| Satisfaction (en pratique de MG): |
266, 314-317; 310, 13-14 |
| Saturomètre: |
249, 24-28 |
Scanner: – thoracique: |
313, 19-21 335, 20-21 |
| Scaphoïde tarsien: |
271, 117 |
| Scapula alata: |
269, 32-33 |
| Schizophrénie: |
325, 13-14 |
| Sciatalgie: |
201, 139; 266, 341; 289, 48-49; 295, 64-66; 309, 11-12; 340, 11-13; 346, 15 |
| Sclérodermie: |
333, 11-13 |
| Sclérose en plaques: |
303, 52-55; 313, 19-21 |
| Sclérothérapie: |
230, 86-91 |
| Scoliose: |
322, 19-21 |
| SCORAD: |
232, 168-174 |
| Scorbut: |
289, 44-47; 296, 8-18 |
| Score ABCDE: |
316, 18-19 |
| SDF: |
289, 44-47; 296, 8-18 |
| Sécheresse buccale: |
324, 10-12 |
| Secrétariat: |
323, 20-23 |
| Secret médical: |
204, 268-272; 206, 390-393 |
Sécurité: – alimentaire: |
210, 60-60 286, 316-321 |
| Sédation: |
304, 42-47 |
| Sédentarité: |
291, 16 |
| Séjour illégal: |
311, 15-19 |
| Semelles: |
248, 420-427 |
| Sensibilité: |
329, 17-19 |
| Septicémie: |
240, 91; 243, 223 |
| Sérologie: |
335, 12-14 |
| Sertraline: |
294, 17 |
| Service d’urgence: |
258, 408-414; 311, 11-12; 312, 13-14 |
Sevrage: – alcoolique: – tabagique: |
279, 37 313, 24-25 250, 78-80; 251, 112-115; 252, 157-158; 265, 284-288; 265, 289-290; 272, 140-141; 272, 150-151; 272, 156-159; 272, 162-165; 272, 166-170; 272, 172-179; 272, 183; 278, 436-439; 278, 444-446; 287, 372-377; 292, 18; 295, 16-21; 296, 8-18; 297, 18-20; 299, 44-47; 314, 15-16; 315, 21-24; 323, 20-23; 325, 13-14; 333, 6-10 |
| Sexualité: |
271, 120-121; 344, 22-23 |
| SGLT-2 inhibiteurs: |
327, 20-25 |
| SIDA: |
250, 56-61; 252, 159; 315, 21-24 |
| Sidéropénie: |
324, 19-20 |
| Signes vitaux: |
300, 16-18 |
| Sinus carotidien: |
210, 93 |
Sinusite: – aigüe: – ethmoïdale: |
228, 535; 319, 16-17 307, 8-10 294, 40-43; 332, 24-25 |
| Sitagliptine: |
266, 328-333 |
| Socio-anthropologie: |
322, 16-18 |
| Sodium oxybate: |
348, 18-19 |
| Soins de santé primaires: |
235, 343-344; 258, 408-414; 295, 22-30; 297, 34-46; 301, 8-15; 334, 17-18 |
| Soins palliatifs: |
285, 282-285; 298, 20-23; 301, 24-28; 304, 42-47; 322, 12-13; 336, 22-24 |
| Somatisation: |
233, 259-261; 268, 402-406 |
| Sommeil: |
244, 240-243; 257, 376-383; 324, 10-12; 326, 6-10; 327, 6-15; 338, 11-13 |
| Somnifères: |
344, 12-13; 344, 16-18 |
| Somnolence: |
292, 54-55 |
| Souffrance au travail: |
305, 22-28 |
| Sourcil: |
222, 180-183 |
| Spasticité: |
282, 152-157 |
| Spécificité: |
329, 17-19 |
| Spirométrie: |
216, 390-393; 272, 160-161; 298, 8-18; 299, 26-32 |
| Spironolactone: |
314, 15-16 |
| Splénectomie: |
215, 336-337; 294, 45-46 |
| SpO2: |
249, 24-28 |
| Spondylarthrite ankylosante: |
332, 22-23; 333, 11-13 |
| Spondylodiscite: |
226, 425 |
| Spondylolisthésis: |
315, 14-15 |
| Spondylolyse: |
217, 444-447; 315, 14-15 |
| Sport: |
216, 386-387; 316, 6-13 |
| SSRI: |
304, 26-28 |
| Stadification: |
321, 15-16 |
| Statines: |
239, 30-35; 256, 332-337; 281, 96-103; 290, 14-16; 303, 44-49; 310, 13-14; 311, 11-12; 312, 13-14; 315, 21-24; 321, 11-12; 322, 12-13; 322, 22-24; 335, 20-21 |
| Statistique: |
329, 17-19 |
| Statut du médecin: |
344, 22-23 |
| Stéatose hépatique: |
225, 356-360; 324, 17-18 |
Sténose: – aortique: – artérielle: – carotidienne: |
277, 376-378; 296, 40-44 217, 459 291, 17 |
| Stérilité: |
248, 438-445; 290, 48-51; 320, 6-16 |
| Stopp&start: |
305, 30-38; 319, 20-21; 328, 6-9 |
Streptocoque: – β-hémolytique: |
252, 144-149; 256, 347; 335, 12-14 346, 23-24 |
Stress: – post-traumatique: |
319, 26-27 237, 475-476 |
| Stroke unit: |
212, 184-186 |
| Stupéfiant: |
344, 12-13 |
| Substituts nicotiniques: |
297, 18-20; 323, 20-23 |
| Suicide: |
287, 384-386; 300, 8-15; 302, 24-31; 307, 8-10; 309, 11-12; 319, 16-17; 326, 11-12; 327, 16-17; 328, 10-12; 331, 11-13; 331, 16-18 |
| Suivi thérapeutique: |
315, 21-24; 315, 21-24 |
| Sulfamides hypoglycémiants: |
327, 20-25 |
| Surdiagnostic: |
298, 20-23; 308, 8-10; 315, 16-20; 330, 20-22 |
Surdité: – brusque: |
209, 8-12; 231, 112-117; 231, 128-131 330, 6-15 |
| Surmédicalisation: |
342, 20-22 |
| Surmenage: |
251, 122-123; 306, 24-32 |
| Suture: |
203, 208-212 |
Symptômes: – inexpliqués: – vasomoteurs: |
268, 402-406; 278, 449 324, 6-9 |
| Syncope: |
210, 93; 211, 134-140; 223, 236-239; 252, 169; 254, 257 |
| Syndrome canalaire: |
264, 250-251; 265, 295-296 |
| Syndrome carcinoïde: |
238, 528-529 |
| Syndrome coronarien: |
233, 244-246 |
| Syndrome d’alcoolisation fœtale: |
302, 24-31; 323, 12-13; 334, 21-22 |
| Syndrome d’apnée obstructive du sommeil: |
voir apnée |
| Syndrome de Brugada: |
290, 26-29 |
| Syndrome de Claude-Bernard-Horner: |
299, 22-24 |
| Syndrome de détresse respiratoire: |
301, 24-28 |
| Syndrome de Down: |
207, 436-445 |
| Syndrome de Guillain-Barré: |
314, 25-26; 338, 11-13 |
| Syndrome de la charnière dorsolombaire: |
316, 26-27 |
| Syndrome de l’intestin irritable: |
326, 11-12; 327, 16-17 |
| Syndrome de Morton: |
328, 13-14 |
| Syndrome de Poland: |
301, 20-21 |
| Syndrome de retard de phase du sommeil: |
294, 18 |
| Syndrome de sécrétion inappropriée d’ADH: |
301, 24-28 |
| Syndrome de Stevens-Johnson: |
251, 111 |
| Syndrome de stress post-traumatique: |
330, 16-17 |
| Syndrome de Südeck: |
208, 486-489 |
| Syndrome de Wallenberg: |
318, 06-15 |
| Syndrome d’Ulysse: |
330, 20-22 |
| Syndrome du messager: |
239, 19 |
| Syndrome dysentérique: |
237, 460-463 |
| Syndrome fémoropatellaire: |
331, 11-13 |
| Syndrome gériatrique: |
299, 26-32; 340, 11-13 |
| Syndrome grippal: |
281, 116-119; 299, 50-52; 315, 25-26; 347, 14-15 |
| Syndrome méningé |
276, 361 |
| Syndrome métabolique: |
242, 168-174; 324, 17-18 |
| Syndrome mixte: |
272, 160-161 |
| Syndrome néphrotique: |
318, 26-27 |
| Syndrome obstructif: |
249, 21 |
| Syndrome oral: |
338, 14-16 |
| Syndrome paranéoplasique: |
275, 317; 321, 6-10 |
| Syndrome parkinsonien: |
254, 248-255 |
| Syndrome restrictif: |
249, 21 |
| Syndrome sérotoninergique: |
304, 34-41 |
| Syphilis: |
286, 343-345; 315, 21-24 |
| Syringome: |
333, 19-20 |
| Système cardiovasculaire: |
295, 16-21 |
| Système de santé: |
324, 10-12; 336, 6-12 |
| Système rénine-angiotensine: |
345, 12 |
| |
(haut de la page)
|
| Tabagisme: |
208, 490-495; 216, 390-393; 232, 178-180; 246, 344-346; 250, 78-80; 251, 112-115; 252, 157-158; 263, 184-188; 265, 284-288; 265, 289-290; 269, 24-27; 272, 140-141; 272, 145-146; 272, 147-148; 272, 150-151; 272, 152-154; 272, 156-159; 272, 162-165; 272, 166-170; 272, 172-179; 272, 183; 278, 444-446; 285, 288-289; 287, 372-377; 289, 27-32; 295, 16-21; 296, 8-18; 299, 44-47; 304, 26-28; 308, 8-10; 314, 15-16; 315, 21-24; 321, 22-23; 324, 13-14; 325, 13-14; 329, 12-14; 334, 21-22; 338, 11-13 |
| Tachycardie: |
199, 26-29; 223, 236-239; 229, 41 |
| Tænia saginata: |
216, 411 |
| Tako-Tsubo: |
331, 23-24 |
| Talalgie: |
328, 13-14 |
| Tamsulosine: |
310, 13-14 |
| Taping: |
312, 23-24 |
| TDAH: |
238, 496-500; 306, 24-32 |
| Télangiectasies nævoïdes: |
231, 124-127 |
| Téléphone: |
214, 280-281; 317, 15-16 |
| Tendinite: |
210, 80-85; 305, 14-16; 335, 20-21 |
Tendinopathie : – médicamenteuse: |
346, 6-14 333, 17-18; 335, 12-14 |
| Tendon d’Achille: |
279, 19; 305, 14-16 |
| Tendon extenseur: |
260, 63 |
| Tennis elbow: |
240, 74-80 |
| Tentative de suicide: |
287, 384-386; 300, 8-15; 326, 11-12; 327, 16-17; 328, 10-12 |
| Tératogénicité: |
234, 276-284 |
Test: – au monofilament: – cutané: – diagnostique: – Elisa: |
213, 216-222 234, 302-309 315, 21-24 200, 88-89 |
| Testicule « yo-yo » |
247, 380-385 |
| Tests hépatiques (altération des -): |
324, 21-22 |
| Tétanos: |
206, 372-374; 220, 70-73 |
| Tétée: |
228, 522-526 |
| Tétraparésie: |
314, 25-26 |
| Thalassémie: |
294, 16 |
| Thélarche: |
245, 284-291 |
| Thérapie cognitivocomportementale: |
330, 16-17 |
| Thermomètre: |
216, 406-408 |
| Trichoépithéliome: |
336, 15-16 |
| Thrombocytose: |
294, 45-46 |
| Thrombo-embolie: |
246, 363; 295, 34-43; 299, 18-20 |
| Thrombopénie: |
281, 125; 294, 46; 317, 23-24 |
| Thrombophilie: |
265, 270-274; 295, 34-43; 345, 12 |
Thrombophlébite: – superficielle: |
274, 271; 297, 24-32; 299, 34-39 327, 18-19 |
Thrombose: – artérielle: – coronarienne: – veineuse: |
345, 12 325, 13-14 299, 34-39 201, 122-124; 293, 24; 306, 8-10; 325, 13-14; 334, 10 |
| THS: |
240, 64-69 |
| Thymorégulateurs: |
282, 140-145 |
| Thyroïdite: |
340, 19-20 |
| Thyrotoxicose: |
341, 13-16 |
| Tibia: |
221, 112-120 |
| Tinea corporis: |
282, 149 |
| Tique: |
274, 255; 284, 228-233; 308, 34-38 |
| TMS: |
283, 186-191 |
| Tophus goutteux: |
326, 13-14 |
| Torsades de pointes: |
319, 6-15 |
Torsion: – ovarienne: – testiculaire: |
305, 22-28 241, 135; 305, 22-28; 313, 6-14 |
| TOT: |
219, 28-34 |
|
Toux:
– chronique
|
208, 484-485; 212, 197; 218, 498-505; 227, 481; 300, 40-46; 333, 23-24 323, 12-13; 337, 21-23 |
Toxicité: – des médicaments: |
211, 122-123; 344, 12-13 301, 36-44 |
| Toxicomanie: |
216, 396-403; 267, 358-362; 279, 20-21; 338, 17-18 |
| Toxidermie médicamenteuse: |
331, 6-10; 338, 14-15 |
| Toxine botulinique: |
282, 152-157 |
| Toxoplasmose: |
246, 344-346; 276, 361 |
Traitement: – hormonal substitutif: – non médicamenteux: |
200, 82-84 207, 424-428 297, 24-32 |
| Tramadol: |
296, 58-61 |
| Tranquillisant: |
317, 19-20 |
| Transferrine: |
294, 49 |
Traumatisme: – crânien: – facial: – osseux: |
239, 8-15; 296, 8-18 313, 19-21; 322, 19-21 240, 73 311, 11-12; 312, 13-14 |
| Tremblements: |
217, 448-453 |
| Trijumeau: |
201, 132-137 |
| Trisomie 21: |
207, 436-445 |
| Trochantérite: |
208, 501 |
| Troponine: |
285, 300-301 |
| Troubles alimentaires: |
310, 20-22 |
| Troubles anxio-dépressifs: |
269, 24-27 |
| Troubles bipolaires: |
282, 140-145; 323, 16-17; 344, 12-13 |
| Troubles cognitifs: |
323, 12-13; 323, 16-17; 324, 10-12; 340, 16-17 |
| Troubles de l’attachement: |
206, 364-368 |
| Troubles de la marche: |
254, 248-255; 298, 52-54 |
| Troubles de la personnalité: |
207, 416-420; 321, 21 |
| Troubles d’équilibre: |
221, 145; 254, 248-255 |
| Troubles de rotation: |
248, 420-427 |
| Troubles du comportement: |
317, 6-14; 317, 19-20; 343, 16-17; 344, 16-18 |
| Troubles du rythme: |
325, 20-21 |
| Troubles du rythme circadien: |
294, 18 |
| Troubles du sommeil: |
212, 197; 304, 34-41; 319, 20-21; 321, 11-12 |
| Troubles ioniques: |
239, 43; 243, 212-217 |
| Troubles moteurs: |
329, 12-14 |
| Troubles musculosquelettiques: |
238, 512-521 |
| Troubles neuropsychologiques: |
324, 10-12 |
| Trouble obsessionnel compulsif: |
295, 32-33 |
| Troubles phosphocalciques: |
301, 36-44 |
| TSH: |
292, 8-14 |
| Tuberculose: |
252, 159 |
| Tularémie: |
215, 357 |
Tuméfaction: – pédiculée: |
256, 329; 317, 17-18 269, 19 |
Tumeur: – bronchique bénigne: – cervicale: – médullaire: |
330, 23-24 249, 8-13 317, 21-22 |
| TVT: |
219, 28-34 |
| |
(haut de la page)
|
Ulcère: – chronique: – de la cornée: – gastrique: |
307, 22-28 291, 20-21 203, 229-235 229, 41; 332, 22-23 |
| Uméclidinium: |
337, 11 |
| Urétrite: |
292, 23-24 |
Urgence: – psychiatrique: |
307, 22-28; 313, 6-14; 316, 18-19 316, 18-19; 331, 16-18 |
| Urologie: |
305, 8-12; 313, 6-14 |
|
Urticaire:
– chronique:
|
223, 233-235; 258, 435; 304, 34-41; 319, 26-27; 331, 6-10 333, 21-22; 338, 20-24 |
| Usagers de drogues: |
204, 282-287; 258, 408-414 |
| |
|
|
Vaccination:
– anti-diphtérie/tétanos – anti-diphtérie/tétanos/coqueluche – anti-grippe H1N1: – anti-HPV: – anti-influenza: – anti-méningococcique: – anti-papillomavirus: – anti-pneumococcique:
– anti-rotavirus: – anti-rougeoleuse: – anti-RRO: – anti-varicelleux: – BCG: – du voyageur:
|
244, 246-247; 271, 112-114; 298, 20-23; 301, 24-28; 322, 12-13; 333, 17-18; 344, 12-13; 344, 22-23; 345, 18-19; 346, 15; 346, 18-21; 347, 14-15 348, 15 206, 372-374 220, 70-73; 266, 321-323 332, 12-14 245, 294-295; 250, 64-65; 288, 432-433 205, 320-321; 325, 6-9; 345, 15-16 291, 28 338, 11-13; 345, 20-21 205, 320-321; 288, 432-433; 291, 28; 300, 40-46; 310, 23-25; 323, 20-23; 341, 13-16 235, 361-363; 300, 16-18 288, 434-437 300, 16-18 291, 28; 337, 16-18 345, 12 298, 26-29; 329, 17-19 |
| Vaginite: |
208, 497-499 |
| Valgum: |
248, 420-427 |
| Valproate: |
323, 16-17 |
| Valvuloplastie percutanée: |
277, 376-378 |
| Vapoteur: |
333, 6-10 |
| Varénicline: |
250, 78-80; 272, 156-159; 328, 10-12 |
| Varice: |
303, 26-31 |
| Varicelle: |
234, 313; 238, 506-509 |
| Varicocèle: |
230, 86-91 |
| Varum: |
248, 420-427 |
| Vascularite: |
336, 19-21 |
| Vécu du patient: |
248, 430-432 |
| Vergetures: |
305, 14-16 |
| Verrue: |
299, 8-17; 334, 19-20 |
| Vertiges: |
221, 145; 223, 257; 233, 248-254; 236, 421; 303, 52-55; 318, 06-15 |
| Vésicule |
320, 18-19 |
| Viande rouge: |
313, 22-23 |
| Vie privée: |
204, 268-272 |
Vieillissement: – de la peau: |
220, 85-89; 225, 344-345 289, 8-19 |
Violence: – conjugale: – psychologique: |
237, 440-447; 260, 76-77; 317, 15-16 202, 156-160 |
| Virus respiratoire syncytial: |
337, 6-10 |
| Vision (baisse de -): |
234, 288-290 |
Vitamine: – B12: – C: – D: |
236, 384-391 289, 44-47; 296, 8-18 286, 326-329; 298, 44-50; 300, 26-34; 301, 36-44; 308, 30-33; 313, 15-16; 318, 16-17; 332, 12-14; 340, 11-13 |
| Volvulus gastrique: |
323, 18-19 |
| Vomissements: |
340, 11-13 |
| Vulvovaginite: |
292, 23-24 |
| |
(haut de la page)
|
| Wheezing: |
337, 6-10 |
| Wolf Parkinson White: |
265, 281 |
| |
(haut de la page)
|
| Xérostomie: |
340, 11-13 |
| |
(haut de la page)
|
| Yersiniose: |
280, 81 |
| |
|
| Z-drugs: |
344, 12-13 |
| Zona: |
236, 421; 266, 341; 276, 345; 313, 17-18; 341, 13-16 |
| Zoonose: |
321, 13-14 |
| Zyka: |
338, 11-13 |
| |
(haut de la page)
|